Search

Your search keyword '"Zhao N"' showing total 6,756 results
Start Over Author "Zhao N"
6,756 results on '"Zhao N"'

1. Development and Validation of the Healthcare-Seeking Intention Questionnaire in Patients with Diabetic High-Risk Foot

Author

Wang H, Li N, Ye Y, Zhao N, Liu M, Xu M, and Zhou Q

Subjects
healthcare-seeking intention, questionnaire development, high-risk foot, patients., Medicine (General), R5-920
Abstract

Honglin Wang,1,2,* Na Li,1,3,4,* Ying Ye,5 Nan Zhao,6 Meizi Liu,1 Min Xu,3 Qiuhong Zhou3,4 1Xiangya School of Nursing, Central South University, Changsha, People’s Republic of China; 2School of Health and Nursing, Guangzhou Huali College, Jiangmen, People’s Republic of China; 3Teaching and Research Section of Clinical Nursing, Xiangya Hospital of Central South University, Changsha, People’s Republic of China; 4National Clinical Research Center for Geriatric Disorders, Xiangya Hospital of Central South University, Changsha, People’s Republic of China; 5Department of Nursing, First People’s Hospital of Yunnan, Kunming, People’s Republic of China; 6School of Nursing, Zhengzhou Shuqing Medical College, Zhengzhou, People’s Republic of China*These authors contributed equally to this workCorrespondence: Qiuhong Zhou, Teaching and Research Section of Clinical Nursing, Xiangya Hospital of Central South University, Changsha, 410008, People’s Republic of China, Tel +8613786136512, Email 928555448@qq.comObjective: Timely screening and intervention can prevent the development of the diabetic foot. However, delayed visits to the clinic are common among diabetic foot patients. The study aimed to develop and validate a questionnaire to assess healthcare-seeking behavior among patients with diabetic high-risk foot.Methods: The questionnaire of healthcare-seeking intention for patients with diabetic high-risk foot was developed in two phases: (1) Developing the questionnaire: 1) questionnaire items were formulated after literature review, group discussion and semi-qualitative interview; 2) a two-round modified Delphi method was to examine the content validity and the degree of consistency in questionnaire items; 3) conducting pre-survey to revise the questionnaire items. (2) Assessing the internal reliability and construct validity.Results: The final questionnaire consisted of five main themes and 28 items with a five-point rating. Cronbach’s alpha coefficients for the five dimensions were respectively 0.937 (relevant knowledge of diabetic foot), 0.669 (attitudes toward seeking care), 0.896 (social support for seeking care), 0.621 (efficacy in coping with foot symptoms), 0.871 (intention to seek care). The Scale-level Content Validity Index of the five parts was 1.00, 0.80, 1.00, 1.00, and 1.00, respectively. The Kaiser-Meyer-Olkin values for each dimension was greater than 0.7, and the p-value for Bartlett’s test of sphericity was less than 0.05.Conclusion: This questionnaire showed good validity, internal consistency, and reliability. It provided a potentially useful instrument to evaluate healthcare-seeking intention among patients with diabetic high-risk foot.Keywords: healthcare-seeking intention, questionnaire development, high-risk foot, patients

Published
2024

2. Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF

Author

Liu D, Tong J, Chen E, Wang L, Xue L, Zhang X, Zhao N, Hu X, and Zheng C

Subjects
high-risk acute promyelocytic leukemia, all-trans retinoic acid, arsenic trioxide, realgar–indigo naturalis formula, anthracyclines, event-free survival, Diseases of the blood and blood-forming organs, RC633-647.5
Abstract

Dan Liu, Juan Tong, Erling Chen, Li Wang, Lei Xue, Xuhan Zhang, Na Zhao, Xing Hu, Changcheng Zheng Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui Province, People’s Republic of ChinaCorrespondence: Changcheng Zheng, Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Lujiang Road No. 17, Hefei, Anhui Province, 230001, People’s Republic of China, Email zhengchch1123@ustc.edu.cnBackground: The aim of the study was to evaluate the efficacy and safety of induction and consolidation with all-trans retinoic acid (ATRA) +arsenic trioxide (ATO) +anthracyclines and maintenance with ATRA +Realgar-Indigo naturalis formula (RIF) for high-risk APL.Methods: Twenty-one patients with high-risk APL treated with ATRA+ATO+ anthracyclines for induction and consolidation and ATRA+RIF for maintenance from 2012 to 2021 were analyzed. Endpoints include morphological complete remission (CR) and complete molecular remission (CMR), early death (ED) and relapse, survival and adverse events (AEs).Results: After induction treatment, all 21 patients (100%) achieved morphological CR and 14 people (66.7%) achieved CMR. Five of the 21 patients did not undergo immunological minimal residual disease (MRD) examination after induction; however, 14 of the remaining 16 patients were MRD negative (87.5%). The median time to achieve CR and CMR was 26 days (range: 16– 44) and 40 days (range: 22– 75), respectively. The cumulative probability of achieving CR and CMR in 45 days was 100% and 76.2% (95% CI: 56.9– 91.3%), respectively. All patients achieved CMR and MRD negativity after the three courses of consolidation treatment. The median follow-up was 66 months (25– 142), with no central nervous system relapse and bone marrow morphological or molecular relapse until now, and all patients survived with 100% overall survival and 100% event-free survival. Grade 4 adverse events (AEs) were observed in 3 patients (14.3%) during the induction period including arrhythmia (n = 1), pulmonary infection (n = 1) and respiratory failure (n = 1); and the most frequent grade 3 AEs were pulmonary infection, accounting for 62.0% and 28.6%, respectively, during induction and consolidation treatment, followed by neutropenia, accounting for 42.9% and 38.1%, respectively.Conclusion: For newly diagnosed high-risk APL patients, induction and consolidation with ATRA+ATO+anthracyclines and maintenance with ATRA+RIF is a highly curative treatment approach.Keywords: high-risk acute promyelocytic leukemia, all-trans retinoic acid, arsenic trioxide, realgar–Indigo naturalis formula, anthracyclines, event-free survival

Published
2024

3. Caffeine in Hepatocellular Carcinoma: Cellular Assays, Animal Experiments, and Epidemiological Investigation

Author

Shan L, Zhao N, Wang F, Zhai D, Liu J, and Lv X

Subjects
coffee, caffeine, hepatocellular carcinoma, adenosine, adenosine receptor, Pathology, RB1-214, Therapeutics. Pharmacology, RM1-950
Abstract

Liang Shan,1– 4,* Ning Zhao,2– 4,* Fengling Wang,1 Dandan Zhai,1 Jianjun Liu,1 Xiongwen Lv2– 4 1Department of Pharmacy, the Second People’s Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, Anhui, 230011, People’s Republic of China; 2Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Medical University, Hefei, 230032, People’s Republic of China; 3Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, 230032, People’s Republic of China; 4The Key Laboratory of Major Autoimmune Diseases, Hefei, Anhui Province, 230032, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jianjun Liu, Department of Pharmacy, the Second People’s Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, Anhui, 230011, People’s Republic of China, Tel +86 551 62965335, Fax +86 551 62965335, Email Jianjun_liu2020@163.com Xiongwen Lv, Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Medical University, Hefei, 230032, People’s Republic of China, Tel +86 55165161000, Fax +86 551 65161000, Email Xiongwen_lv2019@163.comAbstract: The use of caffeine in treating various liver diseases has made substantial progress in the past decade owing to advances in science, technology, and medicine. However, whether caffeine has a preventive effect on hepatocellular carcinoma (HCC) and its mechanism are still worth further investigation. In this review, we summarize and analyze the efficacy and safety of caffeine in the prevention of HCC. We conducted a review of articles published in PubMed and Web of Science in the past 2 decades until December 6, 2023, which were searched for using the terms “Caffeine” and “Hepatocellular Carcinoma.” Studies have found that coffee intake is negatively correlated with HCC risk, especially caffeinated coffee. Recent studies have found that caffeine has beneficial effects on liver health, decreasing levels of enzymes responsible for liver damaging and slowing the progression of hepatic fibrosis and cirrhosis. Caffeine also acts against liver fibrosis through adenosine receptors (ARs), which promote tissue remodeling by inducing fibrin and collagen production. Additionally, new studies have found that moderate consumption of caffeinated beverages can decrease various the levels of various collagens in patients with chronic hepatitis C. Furthermore, polyphenolic compounds in coffee can improve fat homeostasis, reduce oxidative stress, and prevent liver steatosis and fibrosis. Moreover, many in vitro studies have shown that caffeine can protect liver cells and inhibit the activation and proliferation of hepatic stellate cells. Taken together, we describe the benefits of caffeine for liver health and highlight its potential values as a drug to prevent various hepatic diseases. As a protective agent of liver inflammation, non-selective AR inhibitor caffeine can inhibit the growth of HCC cells by inhibiting adenosine and AR binding to initiate immune response, providing a basis for the future development of caffeine as an adjuvant drug against HCC.Keywords: coffee, caffeine, hepatocellular carcinoma, adenosine, adenosine receptor

Published
2024

4. Prevalence and Associated Factors of Thyroid Nodules Among 52,003 Chinese ‘Healthy’ Individuals in Beijing: A Retrospective Cross-Sectional Study

Author

Xu J, Lau P, Ma Y, Zhao N, Yu X, Zhu H, and Li Y

Subjects
thyroid nodule, prevalence, risk factor, logistic regression analysis, Public aspects of medicine, RA1-1270
Abstract

Jin Xu,1 Phyllis Lau,2 Yong Ma,3 Na Zhao,4 Xuezhong Yu,1 Huadong Zhu,1 Yi Li1 1Emergency Department, The State Key Laboratory for Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China; 2Department of General Practice, The University of Melbourne, Melbourne, VIC, Australia; 3Department of Emergency Medicine, Peking University People’s Hospital, Beijing, People’s Republic of China; 4Department of Anesthesiology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Yi Li, Emergency Department, The State Key Laboratory for Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, People’s Republic of China, Tel + 86 10 6915 9128, Email billliyi@aliyun.comIntroduction: The prevalence of thyroid nodules has been increasing, and there are few research data on the risk factors of thyroid nodules in the Chinese population. In this study, we aimed to determine the prevalence and risk factors of thyroid nodules by retrospectively investigating the physical examination records of a cohort of “healthy” individuals in Beijing, China.Methods: This was a retrospective cross-sectional study. The database of a Medical Examination Centre (MEC) was searched. Physical examination data, blood test data, and ultrasound examination data, etc., from 2015 to 2017 were accessed. Only those that recorded a thyroid ultrasound were included. Chi-square test and t-test were used to compare clinical features of individuals’ age, gender, body mass index, blood pressure, blood glucose, blood lipids, uric acid, and presence of fatty liver. Risk factors for thyroid nodules were determined using multivariate logistic regression.Results: A total of 52,003 records, which included 19,901 cases with thyroid nodules, were examined. The overall prevalence rate was 38.3% (19,901/52,003): 30.2% (6,726/22,305) and 44.4% (13,175/29,698) in men and women, respectively. Of 52,003 cases, only 35,420 cases had records of all nodule-related metabolic abnormalities and were selected for cross-sectional determination of related risk factors of thyroid nodules. In male, relationships were found between thyroid nodules and increased age (p < 0.001), impaired fasting glucose (p = 0.044), diabetes (p = 0.047), decreased HDL-C (p = 0.018) and prostatic hyperplasia (p < 0.001). And in female, relationships were found between thyroid nodules and increased age (p < 0.001) and decreased HDL-C (p < 0.001).Conclusion: Thyroid nodules are common in China. This study found that thyroid nodules are associated with several metabolic indicators or metabolic diseases, although the mechanism is unclear. Further research is needed.Keywords: thyroid nodule, prevalence, risk factor, logistic regression analysis

Published
2024

5. Clinical Features of Patients with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease and Isolated Seizure Symptoms

Author

Yang Y, Zhang C, Cao C, Su W, Zhao N, and Yue W

Subjects
myelin oligodendrocyte glycoprotein, antibody-associated disease, seizure, clinical features, anti-epilepsy drugs, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571, Neurology. Diseases of the nervous system, RC346-429
Abstract

Yun Yang,1,2 Chao Zhang,1 Chen Cao,3 Wenhua Su,1 Na Zhao,1 Wei Yue1,4 1Department of Neurology, Clinical College of Neurology, Neurosurgery, and Neurorehabilitation, Tianjin Medical University, Tianjin Huanhu Hospital, Tianjin, People’s Republic of China; 2Department of Neurology, The Second Hospital of Tianjin Medical University, Tianjin, People’s Republic of China; 3Department of Medical Imageology, Tianjin Huanhu Hospital, Tianjin, People’s Republic of China; 4Department of Biomedical Engineering, Tianjin University, Tianjin, People’s Republic of ChinaCorrespondence: Wei Yue, Department of Neurology, Tianjin Huanhu Hospital, 6 Jizhao Road, Tianjin, 300350, People’s Republic of China, Fax +862259065662, Email hhyuewei2021@163.comBackground: Myelin oligodendrocyte glycoprotein (MOG) antibody–associated encephalitis is a new clinical phenotype of inflammatory demyelinating diseases. Some MOG antibody–positive patients with central nervous system demyelinating events present with isolated seizures. However, there are gaps in the epidemiological knowledge regarding seizures with MOG antibody–associated encephalitis in adults. This study characterized the clinical features and treatment of MOG antibody–positive patients with isolated seizures.Methods: We reviewed all the patients admitted to Tianjin Huanhu Hospital between Jan. 1st 2017 and Jan. 1st 2022, to screen the MOG antibody–positive patients with isolated seizures, and collected the concerned patients’ information regarding epidemiology, clinical presentations, laboratory and radiological characteristics, electroencephalogram (EEG), treatments, and prognoses.Results: We collected six MOG antibody–positive adult patients who had isolated symptomatic seizures. The mean age of the patients was 33 years (range, 29– 40 years), and five (83.3%) were men. All patients presented with motor seizures, five (83.3%) had cognitive dysfunction, and only one (16.7%) had status epilepticus. Five (83.3%) patients had a good response to immunotherapy and antiseizure medications; only one had a sequela. The cerebrospinal fluid or serum anti-MOG antibody test turned negative over time.Discussion: The most common seizure type in patients with MOG antibody–associated encephalitis with isolated seizures was focal to bilateral tonic-clonic seizures, and most patients had a good prognosis. Adding antiseizure medications were beneficial for MOG antibody–positive patients with seizures. Relapses and sequelae were associated with low-dose, short-time, or delayed therapy, and wide-range demyelinating brain damage.Plain Language Summary: We reported six adult patients with seizures (as the isolated symptom without any ophthalmoneuromyelitis symptom) associated with MOG antibodies. Focal to bilateral tonic-clonic seizures are the common seizure type in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Antiseizure medications and immunotherapy are beneficial for treating MOG antibody–associated encephalitis with seizures. Many patients had good or complete recovery; low-dose, short-time, or delayed therapy is associated with relapses and sequelae. Emphasized the MOG antibodies testing should be relevant in patients with isolated seizures, particularly occurred in clusters, to guarantee the acute management timely.Keywords: myelin oligodendrocyte glycoprotein, antibody-associated disease, seizure, clinical features, antiseizure medications

Published
2024

6. Selinexor Synergistically Promotes the Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia by Inhibiting Glycolytic Function and Downregulating the Expression of DNA Replication Genes

Author

Jiang J, Wang Y, Liu D, Wang X, Zhu Y, Tong J, Chen E, Xue L, Zhao N, Liang T, and Zheng C

Subjects
venetoclax, selinexor, acute myeloid leukemia, glycolytic function, dna replication-related genes, Immunologic diseases. Allergy, RC581-607
Abstract

Jiqian Jiang,1 Yan Wang,1 Dan Liu,1 Xiaoyu Wang,1 Yingqiao Zhu,1 Juan Tong,1 Erling Chen,1 Lei Xue,1 Na Zhao,1 Tingting Liang,2 Changcheng Zheng1 1Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People’s Republic of China; 2The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People’s Republic of ChinaCorrespondence: Changcheng Zheng, Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Lujiang Road No. 17, Hefei, 230001, People’s Republic of China, Tel/Fax +86-551-62284476, Email zhengchch1123@ustc.edu.cnIntroduction: The BCL-2 inhibitor venetoclax has been widely used in the treatment of acute myeloid leukemia (AML); however, AML patients treated with venetoclax gradually develop resistance. The exportin-1 (XPO1) inhibitor selinexor can synergistically promote the antileukemia activity of venetoclax, but the mechanism remains unclear.Methods and Results: Annexin V/7-aminoactinomycin D assays were used to examine the effects of a combination of venetoclax and selinexor (VEN+SEL) on AML cell lines and primary AML cells. RNA sequencing and oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) determinations by a Seahorse XF analyzer were employed to investigate the molecular mechanism of the toxicity of the VEN+SEL combination to AML cells. The cytotoxicity of NK cell combined with VEN+SEL combination was assessed in vitro using flow cytometry. VEN+SEL enhanced the apoptosis of AML cells (KG-1A and THP-1) and primary AML samples in vitro. The ECAR and OCR results demonstrated that the VEN+SEL combination significantly inhibited glycolytic function. RNA sequencing of THP-1 cells demonstrated that DNA replication-related genes were downregulated after treatment with the VEN+SEL combination.Conclusion: This study indicated that selinexor can synergistically enhance the antileukemia activity of venetoclax in AML cells in vitro by inhibiting glycolytic function and downregulating DNA replication-related genes. Based on our experimental data, combining selinexor with venetoclax is an appropriate advanced treatment option for AML patients.Keywords: venetoclax, selinexor, acute myeloid leukemia, glycolytic function, DNA replication-related genes

Published
2023

7. Advanced Glycation End Products Downregulate Connexin 43 and Connexin 40 in Diabetic Atrial Myocytes via the AMPK Pathway

Author

Yang F, Liu HH, Zhang L, Zhang XL, Zhang J, Li F, Zhao N, Zhang ZY, Kong Q, Liu XY, Wu Y, Yu ZM, Qian LL, and Wang RX

Subjects
diabetes, atrial fibrillation, advanced glycosylation end products, adenosine 5’-monophosphate-actived protein kinase, connexin, Specialties of internal medicine, RC581-951
Abstract

Fan Yang,1,&ast; Huan-Huan Liu,2,&ast; Lei Zhang,1,&ast; Xiao-Lu Zhang,1 Jie Zhang,1 Feng Li,1 Ning Zhao,2 Zhi-Yuan Zhang,1 Qi Kong,1 Xiao-Yu Liu,1 Ying Wu,1 Zhi-Ming Yu,1 Ling-Ling Qian,1 Ru-Xing Wang1,2 1Department of Cardiology, the Affiliated Wuxi People’s Hospital of Nanjing Medical University, Wuxi, 214023, People’s Republic of China; 2Wuxi School of Medicine, Jiangnan University, Wuxi, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Ling-Ling Qian; Ru-Xing Wang, Department of Cardiology, the Affiliated Wuxi People’s Hospital of Nanjing Medical University, Wuxi, 214023, People’s Republic of China, Tel +0086-510-85351593, Email qianlingling@njmu.edu.cn; ruxingw@aliyun.comPurpose: Diabetes mellitus is an independent risk factor for atrial fibrillation (AF), which may be related to accumulation of advanced glycation end products (AGEs). However, the mechanisms involved are not completely clear. Abnormality of gap junction proteins, especially connexin 43 (Cx43) and connexin 40 (Cx40) in atrial myocytes, is an important cause of increased susceptibility of AF. The aim of our work is to investigate the mechanism of dysregulated Cx43 and Cx40 in atrial myocytes of diabetic rats.Methods: We established a type 1 diabetic rat model by intraperitoneal injection of streptozotocin. HL-1 cells and primary rat atrial myocytes were treated with AGEs in vitro. Using Western blotting, immunofluorescence staining, immunohistochemistry, and lucifer yellow diffusion measurements, we investigated dysregulation of Cx43 and Cx40 and its mechanism in atrial myocytes of diabetic rats.Results: Accumulation of AGEs was found in diabetic rats. The expression of Cx43 and Cx40 was reduced in the atrium of diabetic rats, accompanied by the decrease of phosphorylated Adenosine 5’-monophosphate-activated protein kinase (p-AMPK). Similar results were found in cultured HL-1 cells and primary rat atrial myocytes, suggesting a role of AGEs on gap junction proteins. An AMPK agonist, 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR), reversed the down-regulated Cx43 expression induced by AGEs stimulation. More importantly, lucifer yellow diffusion assay showed that AGEs significantly affected gap junctional function, and these changes were reversed by AICAR.Conclusion: Thus, we conclude that AGEs cause dysregulation of Cx43 and Cx40 in diabetic atria via the AMPK pathway, thereby leading to gap junction dysfunction, which may contribute to the increased AF susceptibility in diabetes.Keywords: diabetes, atrial fibrillation, advanced glycosylation end products, adenosine 5’-monophosphate-activated protein kinase, connexin

Published
2023

8. Integrated Analysis of Non-Coding RNA and mRNA Expression Profiles in Exosomes from Lung Tissue with Sepsis-Induced Acute Lung Injury

Author

Deng W, Lu Y, Hu P, Zhang Q, Li S, Yang D, Zhao N, Qian K, and Liu F

Subjects
sepsis, acute lung injury, inflammation, lung tissue exosomes, cerna networks, Pathology, RB1-214, Therapeutics. Pharmacology, RM1-950
Abstract

Wei Deng,1,2 Yanhua Lu,1,2 Ping Hu,1,2 Qingqing Zhang,1,2 Shuangyan Li,1,2 Dong Yang,1,2 Ning Zhao,1,2 Kejian Qian,1,2 Fen Liu1,2 1Department of Critical Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of China; 2Medical Innovation Center, First Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of ChinaCorrespondence: Fen Liu, Email liufen9934@163.comBackground: Acute lung injury (ALI) is associated with a high mortality rate; however, the underlying molecular mechanisms are poorly understood. The purpose of this study was to investigate the expression profile and related networks of long noncoding RNAs (lncRNAs), microRNAs (miRNAs), and mRNAs in lung tissue exosomes obtained from sepsis-induced ALI.Methods: A mouse model of sepsis was established using the cecal ligation and puncture method. RNA sequencing was performed using lung tissue exosomes obtained from mice in the sham and CLP groups. Hematoxylin-eosin staining, Western blotting, immunofluorescence, quantitative real-time polymerase chain reaction, and nanoparticle tracking analysis were performed to identify relevant phenotypes, and bioinformatic algorithms were used to evaluate competitive endogenous RNA (ceRNA) networks.Results: Thirty lncRNA-miRNA-mRNA interactions were identified, including two upregulated lncRNAs, 30 upregulated miRNAs, and two downregulated miRNAs. Based on the expression levels of differentially expressed mRNAs(DEmRNAs), differentially expressed LncRNAs(DELncRNAs), and differentially expressed miRNAs(DEmiRNAs), 30 ceRNA networks were constructed.Conclusion: Our study revealed, for the first time, the expression profiles of lncRNA, miRNA, and mRNA in exosomes isolated from the lungs of mice with sepsis-induced ALI, and the exosome co-expression network and ceRNA network related to ALI in sepsis.Keywords: sepsis, acute lung injury, inflammation, lung tissue exosomes, ceRNA networks

Published
2023

9. Resveratrol Ameliorates Imiquimod-Induced Psoriasis-Like Mouse Model via Reducing Macrophage Infiltration and Inhibiting Glycolysis

Author

Wang Y, Qi C, Feng F, Hu X, Zhao N, Zhao J, Di T, Meng Y, Yang D, Zhu H, Zhang X, and Li P

Subjects
resveratrol, psoriasis, macrophage, ampk, glycolysis, Pathology, RB1-214, Therapeutics. Pharmacology, RM1-950
Abstract

Yazhuo Wang,1,2 Cong Qi,1,2 Fang Feng,3 Xueqing Hu,3 Ning Zhao,1,2 Jingxia Zhao,1 Tingting Di,1 Yujiao Meng,1 Danyang Yang,1,2 Haoyue Zhu,1,2 Xiawei Zhang,1,2 Ping Li,1 Yan Wang1 1Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Institute of Traditional Chinese Medicine, Beijing Key Laboratory of Clinic and Basic Research with Traditional Chinese Medicine on Psoriasis, Beijing, People’s Republic of China; 2Capital Medical University, Beijing, 100069, People’s Republic of China; 3Beijing University of Chinese Medicine, Beijing, 100029, People’s Republic of ChinaCorrespondence: Ping Li; Yan Wang, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Institute of Traditional Chinese Medicine, Beijing Key Laboratory of Clinic and Basic Research with Traditional Chinese Medicine on Psoriasis, Beijing, 100010, People’s Republic of China, Email liping61871@sina.com; wangyan11339@bjzhongyi.comPurpose: Resveratrol (Res) is a natural polyphenol with anti-inflammatory and immunomodulatory effects. Alterations in metabolic pathways have been studied in psoriasis. This study is aimed to further explore the potential molecular mechanism of psoriasis improvement by Res.Patients and Methods: Imiquimod (IMQ)-induced psoriasis-like mouse model was established to observe the effects of Res. NanoString nCounter Metabolic Pathways Panel was used to analyze the changed mRNA and qRT-PCR was used for validation. Flow cytometry was used to analyze immune cell subsets in skin lesions. In vitro, we observed the effects of Res on R848-stimulated macrophages glycolysis and inflammation.Results: Res reduced the proliferation of keratinocytes and the secretion of inflammatory cytokines in IMQ-induced psoriasis-like mouse model. Psoriasis model skin lesions were in a state of hypoxia, with upregulated glycolysis and downregulated AMPK activity. Res inhibited the levels of hypoxia-related genes (hif1α, hif3α) and glycolysis-related genes (hk1, ldha), meanwhile increased the levels of AMPK genes (prkaa1, prkaa2). Flow cytometry analysis revealed that Res decreased the infiltration of macrophages in psoriasis-like lesions. In addition, Res decreased the secretion of macrophage-associated pro-inflammatory cytokines (IL-23, TNF-α, IL-1β). In vitro, Res diminished the secretion of IL-23, TNF-α, IL-1β, and lactate by R848-stimulated macrophages and activated AMPK.Conclusion: This study suggested that Res diminished psoriasis symptoms by inhibiting macrophages infiltration and inhibiting glycolysis, which providing novel insights into the underlying mechanisms of therapeutic action of Res in the treatment of psoriasis.Keywords: resveratrol, psoriasis, macrophage, AMPK, glycolysis

Published
2023

10. Heterogeneity of CD40 Expression in Different Types of High-Risk Endometrial Cancer Affects Discordant Prognostic Outcomes

Author

Zhao N, Sun B, Cheng Y, and Wang J

Subjects
endometrial cancer, cd40, pd-l1, heterogeneity, immune checkpoint, Therapeutics. Pharmacology, RM1-950
Abstract

Na Zhao,1,2,&ast; Bowen Sun,1,&ast; Yuan Cheng,1 Jianliu Wang1 1Department of Gynecology and Obstetrics, Peking University People’s Hospital, Beijing, 100044, People’s Republic of China; 2Department of Obstetrics and Gynecology, Peking University International Hospital, Beijng, 102206, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Jianliu Wang; Yuan Cheng, Department of Gynecology and Obstetrics, Peking University People’s Hospital, Beijing, 100044, People’s Republic of China, Tel +86-10-88324385 ; +86-10-88324474, Email wangjianliu1203@163.com; chengyuan@bjmu.edu.cnBackground: The role of immune checkpoint inhibitors in endometrial cancer is limited. At present, the anti-programmed cell death protein 1 (anti-PD-1) antibody is only used in patients with recurrence or metastasis. CD40 is an important immune checkpoint, which is expressed in tumor cells and immune cells, but its distribution characteristics in endometrial carcinoma have not been explored.Methods: Sixty-eight cases of primary endometrial carcinoma treated in Peking University People’s Hospital from January 2010 to December 2020 were collected, including 28 cases of poorly differentiated endometrioid adenocarcinoma, 23 cases of serous carcinoma and 17 cases of clear cell carcinoma. The relationship of CD40 expression and PD-L1 expression with their prognosis was analyzed by immunohistochemistry.Results: We found that CD40 had higher expression in non-endometrioid endometrial carcinoma, which lead to the worse prognosis. The effect of high expression of CD40 on the prognosis of endometrioid adenocarcinoma was not significantly different, and most patients with good prognosis. We found that the proportion of CD40 distribution in tumor cells and immune cells may be associated with this heterogeneity.Conclusion: The expression of CD40 in different endometrial cancers may indicate the difference prognosis, which may become a potential target for drug treatment of non-endometrioid endometrial carcinoma.Keywords: endometrial cancer, CD40, PD-L1, heterogeneity, immune checkpoint

Published
2023

11. Performance of Two Matrix-Assisted Laser Desorption Ionization–Time-of-Flight Mass Spectrometry (MALDI-TOF MS) Systems for Identification of the Viridans Group Streptococci

Author

Pan F, Zhao N, Zhao W, Wang C, Sun Y, Zhang H, Qin J, and Liu Q

Subjects
maldi-tof ms, viridans group streptococci, identification, streptococcus pneumoniae, Infectious and parasitic diseases, RC109-216
Abstract

Fen Pan,1,2,&ast; Na Zhao,3,&ast; Wantong Zhao,1 Chun Wang,1 Yan Sun,1 Haomin Zhang,3 Juanxiu Qin,3 Qian Liu,3 Hong Zhang1,2 1Department of Clinical Laboratory, Shanghai Children’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China; 2Institute of Pediatric Infection, Immunity, and Critical Care Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, 200062, People’s Republic of China; 3Department of Laboratory Medicine, RenJi Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Hong Zhang, Department of Clinical Laboratory, Shanghai Children’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China, Tel +86 189 1712 8200, Email schjyk2015@126.com Qian Liu, Department of Laboratory Medicine, RenJi Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, People’s Republic of China, Email qq2005011@163.comBackground: Due to similar colony morphology among viridans group streptococci (VGS), the differentiation of VGS species remains difficult in routine clinical microbiology. Recently, matrix-assisted laser desorption ionization–time-of-flight mass spectrometry (MALDI-TOF MS) has been described as a fast method for identifying various bacteria at species level, and also for the VGS strains.Methods: A total of 277 VGS isolates were identified with the two MALDI-TOF MS systems (VITEK MS and Bruker Biotyper). The tuf and rpoB gene sequencing was used as the reference identification method for comparison.Results: Based on tuf and rpoB gene sequencing, 84 isolates were S. pneumoniae and 193 strains were other VGS isolates including S. anginosus group (n=91, 47.2%), S. mitis group (n=80, 41.5%), S. bovis group (n=11, 5.7%), S. salivarius group (n=10, 5.2%), and S. mutans group (n=1, 0.5%). VITEK MS and Bruker Biotyper accurately identified 94.6% and 89.9% of all VGS isolates, respectively. VITEK MS showed better identification results than Bruker Biotyper for S. mitis group including S. pneumoniae and S. bovis group, but for other VGS isolates, two MALDI-TOF MS systems showed comparable identification performance. However, VITEK MS was able to identify S. gallolyticus to the subspecies level with high-confidence (S. gallolyticus ssp. pasteurianus), while the Bruker Biotyper system could not. While Bruker Biotyper system could be able to correctly differentiate the subspecies of S. salivarius from S. vestibularis, VITEK MS poorly identify.Conclusion: This study demonstrated that two MALDI-TOF MS systems allowed discrimination for most VGS isolates with different identification performance, but Bruker Biotyper could produce more misidentifications and VITEK MS system. It is crucial to be familiar with the performance of MALDI-TOF MS systems used in clinical microbiology.Keywords: MALDI-TOF MS, viridans group streptococci, identification, Streptococcus pneumoniae

Published
2023

12. Neutrophil Extracellular Traps Induce Alveolar Macrophage Pyroptosis by Regulating NLRP3 Deubiquitination, Aggravating the Development of Septic Lung Injury

Author

Cui Y, Yang Y, Tao W, Peng W, Luo D, Zhao N, Li S, Qian K, and Liu F

Subjects
sepsis, neutrophil extracellular traps, macrophage pyroptosis, nlrp3 inflammasomes, ubiquitination, oxidative stress, Pathology, RB1-214, Therapeutics. Pharmacology, RM1-950
Abstract

Yamei Cui,&ast; Ying Yang,&ast; Wenqiang Tao, Wei Peng, Deqiang Luo, Ning Zhao, Shuangyan Li, Kejian Qian, Fen Liu Department of Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Fen Liu, Department of Critical Care Medicine, The First Affiliated Hospital of Nanchang University, No. 17 Yongwaizheng Street, Dong Lake District, Nanchang, 330000, People’s Republic of China, Tel +86 0791 88692533, Email liufen9934@163.comBackground: Uncontrolled inflammation is a typical feature of sepsis-related lung injury. The key event in the progression of lung injury is Caspase-1-dependent alveolar macrophage (AM) pyroptosis. Similarly, neutrophils are stimulated to release neutrophil extracellular traps (NETs) to participate in the innate immune response. This study aims to illustrate the specific mechanisms by which NETs activate AM at the post-translational level and maintain lung inflammation.Methods: We established a septic lung injury model by caecal ligation and puncture. We found elevated NETs and interleukin-1b (IL-1β) levels in the lung tissues of septic mice. Western blot and immunofluorescence analyses was utilized to determine whether NETs promote AM pyroptosis and whether degrading NETs or targeting the NLRP3 inflammasome had protective effects on AM pyroptosis and lung injury. Flow cytometric and co-immunoprecipitation analyses verified intracellular reactive oxygen species (ROS) levels and the binding of NLRP3 and ubiquitin (UB) molecules, respectively.Results: Increased NETs production and IL-1β release in septic mice were correlated with the degree of lung injury. NETs upregulated the level of NLRP3, followed by NLRP3 inflammasome assembly and caspase-1 activation, leading to AM pyroptosis executed by the activated fragment of full-length gasdermin D (FH-GSDMD). However, the opposite effect was observed in the context of NETs degradation. Furthermore, NETs markedly elicited an increase in ROS, which facilitated the activation of NLRP3 deubiquitination and the subsequent pyroptosis pathway in AM. Removal of ROS could promote the binding of NLRP3 and ubiquitin, inhibit NLRP3 binding to apoptosis-associated spotted proteins (ASC) and further alleviate the inflammatory changes in the lungs.Conclusion: In summary, these findings indicate that NETs prime ROS generation, which promotes NLRP3 inflammasome activation at the post-translational level to mediate AM pyroptosis and sustain lung injury in septic mice.Keywords: sepsis, neutrophil extracellular traps, macrophage pyroptosis, NLRP3 inflammasomes, ubiquitination, oxidative stress

Published
2023

13. Efficacy and Mechanism of Qianshan Huoxue Gao in Acute Coronary Syndrome via Regulation of Intestinal Flora and Metabolites

Author

Zhao N, Ma Y, Liang X, Zhang Y, Hong D, Wang Y, and Bai D

Subjects
traditional chinese medicine, acute coronary syndrome, 16s rrna, ethanolamine, topical paste, Therapeutics. Pharmacology, RM1-950
Abstract

Ning Zhao,1,2 Yan Ma,3 Xiaoxue Liang,2 Yu Zhang,4 Dacheng Hong,5 Ying Wang,2 Dong Bai2 1Department of Pharmacy, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, People’s Republic of China; 2Formula-Syndrome Research Center, Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, People’s Republic of China; 3Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria; 4Beijing Xiuzheng Pharmaceutical Company, Beijing, People’s Republic of China; 5Department of Pharmaceutical Sciences, University of Vienna, Vienna, AustriaCorrespondence: Dong Bai, Tel +86 13552343081, Fax +8610 64089002, Email baidong2000@126.comPurpose: To study the efficacy of Qianshan Huoxue Gao (QS) in treating acute coronary syndrome (ACS) and to explore the mechanism of action from the perspective of intestinal flora regulation.Methods: Male Sprague–Dawley rats were divided into control, model, QS, and atorvastatin groups; except for the control group, rats underwent ligation of the left anterior descending branch of the coronary artery. Following treatment for 28 days, cardiac function was evaluated using an echocardiographic assay; ELISAs for serum creatine kinase isoenzyme (CK-MB), cardiac troponin I (cTnI), high-sensitivity C-reactive protein (hs-CRP), interleukin (IL)-2 (IL-2), IL-6, and tumor necrosis factor-α (TNF-α); assessment of cardiac enzymes and inflammatory response; hematoxylin and eosin (HE) staining for histopathological changes in the heart, skin, and viscera; 16S rRNA gene sequencing for intestinal flora diversity and structural differences analysis; and we further investigated intestinal contents using metabolomics.Results: Compared with controls, CK-MB and cTnI were increased (P< 0.01); ejection factor and fractional shortening were decreased (P< 0.01); left ventricular internal end-diastolic dimension and left ventricular internal end-systolic dimension were increased (P< 0.01); and IL-2, IL-6, TNF-α, and hs-CRP were increased in the model group. Myocardial damage and inflammation were also observed by HE staining. QS improved these indexes, similar to the atorvastatin group; therefore, QS could effectively treat ACS. QS modulates the structure and abundance of the intestinal flora in ACS model rats, among which Bacteroides, Lactobacillus, and Rikenellaceae_RC9_gut_group are associated with cardiovascular disease. Metabolomics revealed that the intestinal metabolite content changed in ACS, with ethanolamine (EA) being the most relevant metabolite for ACS treatment by QS. EA was significantly positively correlated with Eubacterium xylanophilum group, Ruminococcus, unclassified f__Oscillospiraceae, Intestinimonas, Eubacterium siraeum group, Lachnospiraceae NK4A136 group, and norank f__Desulfovibrionaceae.Conclusion: QS can effectively treat ACS and can restore regulation of the intestinal flora. EA may be the primary metabolite of QS, exerting a therapeutic effect in ACS.Keywords: traditional Chinese medicine, acute coronary syndrome, 16S rRNA, ethanolamine, topical paste

Published
2023

14. Anti-Arthritic Effect of Edaravone Against Complete Freund Adjuvant Induced Arthritis via Osteoclast Differentiation and HIF-1α–VEGF–ANG-1 Axis

Author

Liu J, Zhao N, Su SH, Gao Y, and Qi B

Subjects
edaravone, oxidative stress, arthritis, inflammation, angiogenesis, osteoclast differentiation, Therapeutics. Pharmacology, RM1-950
Abstract

Jichao Liu,1 Nan Zhao,2 Shi-Han Su,3 Yun Gao,2 Bo Qi4 1Department of Hand and Foot Micro Burn Plastic Surgery, 3201 Hospital, Hanzhong, People’s Republic of China; 2Department of Neurosurgery, The First Hospital of Kunming, Kunming, People’s Republic of China; 3Department of Internal Medicine-Neurology, 920th Hospital of Joint Logistics Support Force, Kunming, People’s Republic of China; 4Department of Orthopaedics, 920th Hospital of Joint Logistics Support Force, Kunming, People’s Republic of ChinaCorrespondence: Bo Qi, Department of Orthopaedics, 920th Hospital of Joint Logistics Support Force, Kunming, 650000, People’s Republic of China, Email kmqb66@sina.comBackground: Bone dysfunction is a crucial problem that occurs during rheumatoid arthritis (RA) disease. Osteoclast plays a significant role in bone resorption and osteoclast differentiation and its enhancement of bone destruction. Edaravone remarkably exhibited free radical scavenging and anti-inflammatory effects. The objective of the current investigation is to comfort the inhibitory effect of Edaravone (ED) against complete Freund adjuvant (CFA) rat model via inhibition of angiogenesis and inflammation.Methods: Subcutaneous injection of CFA (1%) was used to induce arthritis; the rats were divided into different groups and received the oral administration of ED. Paw edema, body weight, and arthritis score were regularly estimated. Biochemical parameters were estimated, respectively. We also estimate the level of hypoxia-inducible factor-1α (HIF-1α), angiopoietin 1 (ANG-1), and vascular endothelial growth factor (VEGF). We also checked into how ED affected the differentiation of osteoclasts utilising a co-culture system with monocytes and synovial fibroblasts in arthritis rats.Results: ED treatment significantly (P< 0.001) suppressed the arthritis score and paw edema and improved the body weight. ED treatment significantly (P< 0.001) altered the antioxidant parameters and pro-inflammatory cytokines: inflammatory mediator nuclear kappa B factor (NF-κB), cyclooxygenase-2 (COX-2), and prostaglandin E2 (PGE2), respectively. Furthermore, ED treatment significantly (P< 0.001) suppressed the level of ANG-1, HIF-1α, and VEGF, respectively. The results suggest that ED suppressed osteoclast differentiation and also decreased the level of cytokines and osteopontin (OPN), receptor activator for nuclear factor-κ B Ligand (RANKL) and macrophage colony stimulating factor (M-CSF) in the co-culture supernatant of monocytes and synovial fibroblasts.Conclusion: Edaravone could mitigate CFA via inhibiting angiogenesis and inflammatory reactions, which may be linked with the HIF-1α–VEGF–ANG-1 axis and also enhance the bone destruction of murine arthritis via suppression of osteoclast differentiation and inflammatory reaction.Keywords: Edaravone, oxidative stress, arthritis, inflammation, angiogenesis, osteoclast differentiation

Published
2023

15. The Glu69Asp Polymorphism of EME1 Gene is Associated with an Increased Risk of Hepatocellular Carcinoma in Guangxi Population, China

Author

Wang Y, Huang X, Su Z, He J, Zhao N, Nie L, Tang Y, Zhao H, and Nong Q

Subjects
eme1, hepatocellular carcinoma, missense polymorphism, pond/ditch water, nomogram, Medicine (General), R5-920
Abstract

Youxin Wang,1,&ast; Xinglei Huang,1,&ast; Zhaohui Su,1,&ast; Junquan He,1 Na Zhao,1 Liyun Nie,1 Yanmei Tang,1 Huiliu Zhao,2 Qingqing Nong1,3 1Department of Environmental Health, School of Public Health, Guangxi Medical University, Nanning, 530021, People’s Republic of China; 2Department of Clinical Laboratory, The Affiliated Tumor Hospital of Guangxi Medical University, Nanning, 530021, People’s Republic of China; 3Guangxi Colleges and Universities Key Laboratory of Prevention and Control of Highly Prevalent Diseases, Guangxi Medical University, Nanning, 530021, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Qingqing Nong, Department of Environmental Health, School of Public Health, Guangxi Medical University, Nanning, 530021, People’s Republic of China, Tel +86 771-5358146, Fax +86 771-5350823, Email nnqq@gxmu.edu.cnBackground: The dysfunction of Essential meiotic endonuclease 1 homolog 1 (EME1) can lead to genomic instability and tumorigenesis. Single nucleotide polymorphisms (SNPs) in the EME1 gene have been reported to be associated with the risk of several cancers, but its association with hepatocellular carcinoma (HCC) has not been investigated. This study aimed to determine the association between EME1 SNPs and the risk of HCC.Methods: This study included 645 HCC patients and 649 healthy controls from a Guangxi population of Southern China, and genotyped three functional SNPs (Glu69Asp: rs3760413A>C, Ile350Thr: rs12450550T>C, and rs11868055A>G) of the EME1 gene utilizing the Agena MassARRAY platform.Results: The rs3760413C variant genotypes (AC+CC: Glu/Asp+Asp/Asp) conferred a 1.419-fold risk of HCC compared to the AA (Glu/Glu) genotype (adjusted OR = 1.419, 95% CI = 1.017– 1.980), and the allele C increased the risk of HCC in a dose-dependent manner (Ptrend = 0.017). Moreover, the effects of the rs3760413C variant genotypes were more pronounced in individuals who drank pond/ditch water (adjusted OR = 3.956, 95% CI = 1.413– 11.076) than in those who never drank (P = 0.033). We further observed that a potential carcinogen microcystin-LR induced more DNA oxidative damages in peripheral blood mononuclear cells from the carriers of rs3760413C variant genotypes than those from the subjects with AA genotype (P = 0.006). A nomogram was also constructed combining the rs3760413A>C polymorphism and environmental risk factors for predicting HCC risk with a good discriminatory ability (concordance index = 0.892, 95% CI: 0.874– 0.911) and good calibration (mean absolute error = 0.005).Conclusion: Our data suggest that the Glu69Asp missense polymorphism (rs3760413) of EME1 gene is associated with the risk of HCC, which may be a susceptible biomarker of HCC in the Guangxi population.Keywords: EME1, hepatocellular carcinoma, missense polymorphism, pond/ditch water, nomogram

Published
2022

16. The Role of Neuro-Immune Interactions in Chronic Pain: Implications for Clinical Practice

Author

Su PP, Zhang L, He L, Zhao N, and Guan Z

Subjects
neuroimmune, chronic pain, glial cells, macrophage, t-cells, Medicine (General), R5-920
Abstract

Po-Yi Paul Su,1 Lingyi Zhang,1,2 Liangliang He,1,3 Na Zhao,1 Zhonghui Guan1 1Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, CA, USA; 2Department of Anesthesiology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People’s Republic of China; 3Department of Pain Management, Xuanwu Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Zhonghui Guan, Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, CA, USA, Tel +415.885.7246, Fax +415.885.7575, Email zhonghui.guan@ucsf.eduAbstract: Chronic pain remains a public health problem and contributes to the ongoing opioid epidemic. Current pain management therapies still leave many patients with poorly controlled pain, thus new or improved treatments are desperately needed. One major challenge in pain research is the translation of preclinical findings into effective clinical practice. The local neuroimmune interface plays an important role in the initiation and maintenance of chronic pain and is therefore a promising target for novel therapeutic development. Neurons interface with immune and immunocompetent cells in many distinct microenvironments along the nociceptive circuitry. The local neuroimmune interface can modulate the activity and property of the neurons to affect peripheral and central sensitization. In this review, we highlight a specific subset of many neuroimmune interfaces. In the central nervous system, we examine the interface between neurons and microglia, astrocytes, and T lymphocytes. In the periphery, we profile the interface between neurons in the dorsal root ganglion with T lymphocytes, satellite glial cells, and macrophages. To bridge the gap between preclinical research and clinical practice, we review the preclinical studies of each neuroimmune interface, discuss current clinical treatments in pain medicine that may exert its action at the neuroimmune interface, and highlight opportunities for future clinical research efforts.Keywords: neuroimmune, chronic pain, glial cells, macrophage, T-cells

Published
2022

17. Hypoparathyroidism Risk After Total Endoscopic Thyroidectomy for Papillary Thyroid Cancer: A Comparison of the Transoral Vestibular and Breast Approaches

Author

Xu W, Teng C, Ding G, and Zhao N

Subjects
hypoparathyroidism, endoscopic, thyroidectomy, papillary thyroid carcinoma, parathyroid hormone, surgery, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Wei Xu, Changsheng Teng, Guoqian Ding, Ning Zhao Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Ning Zhao, Email 13811926363@163.comBackground: This study aimed to compare the risk of hypoparathyroidism between the transoral vestibular approach (TOVA) and the breast approach (BA) in patients undergoing total endoscopic thyroidectomy (TET) for papillary thyroid carcinoma (PTC).Methods: The medical records of 121 PTC patients (all women) who underwent total TET from January 2015 to January 2021 were retrospectively analyzed. Patients were grouped according to surgical approach (BA or TOVA). Clinical status and concentrations of parathyroid hormone (PTH) and calcium were monitored in the perioperative period and 1, 6, and 12 months after surgery.Results: The BA and TOVA groups comprised 101 and 20 patients, respectively. Clinicopathologic and characteristics and surgical data were comparable between the groups. Incidence of transient hypoparathyroidism was significantly lower in the TOVA group than the BA group (10% vs 63.4%; p < 0.01). Incidence of permanent hypoparathyroidism was comparable (5% vs 6.9%). Two days after TET, mean PTH concentration was significantly higher and incidence of abnormal PTH was significantly lower in the TOVA group. The incidence of abnormal calcium concentration 2 days after surgery was significantly lower in the TOVA group. One month after surgery, the mean calcium concentration was significantly higher in the TOVA group. Univariate and multivariate Cox regression analysis suggested that patients who underwent TOVA had a lower risk of transient hypoparathyroidism (hazard ratio 0.05, 95% confidence interval, 0.01– 0.23; p< 0.01). No clinicopathological factors examined were significantly associated with permanent hypoparathyroidism.Conclusion: In patients undergoing TET for PTC, the incidence of transient hypoparathyroidism may be lower with the TOVA than the BA. Surgeons should be aware of the relatively high risk of transient hypoparathyroidism when performing the BA.Keywords: hypoparathyroidism, endoscopic, thyroidectomy, papillary thyroid carcinoma, parathyroid hormone, surgery

Published
2022

18. MBL Binding with AhR Controls Th17 Immunity in Silicosis-Associated Lung Inflammation and Fibrosis

Author

Liu Y, Zhao N, Xu Q, Deng F, Wang P, Dong L, Lu X, Xia L, Wang M, Chen Z, Zhou J, and Zuo D

Subjects
silicosis, mannan-binding lectin, aryl hydrocarbon receptor, signal transducer and activator of transcription 3, th17 cell, Pathology, RB1-214, Therapeutics. Pharmacology, RM1-950
Abstract

Yunzhi Liu,1,2,&ast; Na Zhao,3,&ast; Qishan Xu,1,2 Fan Deng,1 Ping Wang,1,2 Lijun Dong,1,2 Xiao Lu,2 Lihua Xia,3 Mingyong Wang,4 Zhengliang Chen,2 Jia Zhou,2 Daming Zuo1,5 1Department of Medical Laboratory, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, 510515, People’s Republic of China; 2Guangdong Province Key Laboratory of Proteomics, Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, 510515, People’s Republic of China; 3Department of Medical Laboratory, Guangdong Province Hospital for Occupational Disease Prevention and Treatment, Guangzhou, Guangdong, 510399, People’s Republic of China; 4Xinxiang Key Laboratory of Immunoregulation and Molecular Diagnostics, Xinxiang, 453003, People’s Republic of China; 5Microbiome Medicine Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510282, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Jia Zhou, Guangdong Province Key Laboratory of Proteomics, Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, 510515, People’s Republic of China, Tel +86-20-61648220, Fax +86-20-61648221, Email yuguomm@smu.edu.cn Daming Zuo, Department of Medical Laboratory, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, 510515, People’s Republic of China, Tel +86-20-61648552, Fax + 86-20-61648221, Email zdaming@smu.edu.cnObjective: Mannan-binding lectin (MBL), a soluble pattern recognition molecule of the innate immune system, is primarily synthesized in the liver and secreted into the circulation. Low serum level of MBL has been reported to be related to an increased risk of lung diseases. Herein, we aimed to investigate the function of MBL in silicosis-associated pulmonary inflammation.Methods: Serum collected from silicosis patients was tested for correlation between serum MBL levels and Th17 immunity. In vitro studies were performed to further demonstrated the effect of MBL on Th17 polarization. Silica was intratracheally injected in wild type (WT) or MBL-deficient (MBL–/–) mice to induce silicosis-associated lung inflammation and fibrosis. Th17 response was evaluated to explore the effect of MBL on silicosis in vivo.Results: Silicosis patients with high serum MBL levels displayed ameliorative lung function. We demonstrated that serum MBL levels negatively correlated to Th17 cell frequency in silicosis patients. MBL protein markedly reduced expression of IL-17 but enhanced expression of Foxp3 in CD4+ T cells in vitro when subjected to Th17 or Treg polarizing conditions, respectively. The presence of MBL during Th17 cell polarization significantly limited aryl hydrocarbon receptor (AhR) expression and suppressed the signal transducer and activator of transcription 3 (STAT3) phosphorylation. Treatment with the AhR antagonist abolished the effect of MBL on Th17 response. Strikingly, MBL directly bound to AhR and affected its nuclear translocation. Furthermore, MBL–/– mice displayed elevated Th17 cell levels compared with WT mice in response to the silica challenge. The CD4+ T lymphocytes from silica-administrated MBL–/– mice exhibited more AhR expression than the wild-type counterparts.Conclusion: Our study suggested that MBL limited the Th17 immunity via controlling the AhR/STAT3 pathway, thus providing new insight into silicosis and other inflammatory diseases in patients with MBL deficiency.Keywords: silicosis, mannan-binding lectin, aryl hydrocarbon receptor, signal transducer and activator of transcription 3, Th17 cell

Published
2022

19. Association Between Serum Total Bilirubin Level and Lung Function Decline in Patients with COPD: Results from a Pooled Study

Author

Dai C, Wang Z, Deng Z, Wu F, Yang H, Xiao S, Wen X, Zheng Y, Xu J, Lu L, Zhao N, Huang P, Zhou Y, and Ran P

Subjects
total bilirubin, copd, lung function, gold stage, decline, Diseases of the respiratory system, RC705-779
Abstract

Cuiqiong Dai,&ast; Zihui Wang,&ast; Zhishan Deng, Fan Wu, Huajing Yang, Shan Xiao, Xiang Wen, Youlan Zheng, Jianwu Xu, Lifei Lu, Ningning Zhao, Peiyu Huang, Yumin Zhou, Pixin Ran State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Pixin Ran; Yumin Zhou, The State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, No. 195 Dongfeng Xi Road, Guangzhou, 510000, People’s Republic of China, Tel +86-020 83205187, Fax +86-020 81340482, Email pxran@gzhmu.edu.cn; zhouyumin410@126.comBackground: Serum total bilirubin has been reported to have antioxidant properties against chronic respiratory diseases. The objective of our study is to evaluate the association of total bilirubin (TB) with annual lung function decline in COPD patients with different GOLD stages.Methods: This study used pooled data from two observational and prospective cohorts of 612 COPD patients whose TB levels were measured at baseline. The associations between TB and postbronchodilator FEV1, FEV1pred, FVC, FVCpred, FEV1/FVC, and the rate of their decline were all determined using linear regression models in the total population and strata of GOLD stages.Results: Serum TB was positively related to FEV1 and FVC in the total group (β 0.02, 95% CI 0.001∼ 0.02, P = 0.025 and β 0.02, 95% CI 0.002∼ 0.03, P = 0.022, respectively). Additionally, TB was inversely associated with the annual decline in FEV1 and FEV1pred (β 4.91, 95% CI 1.68∼ 8.14, P = 0.025 and β 0.21, 95% CI 0.06∼ 0.36, P = 0.022, respectively) when adjusted for multivariables. After stratification, the significant associations merely persisted in COPD patients with GOLD 2 and GOLD 3– 4.Conclusion: Increased TB level was related to less annual decline in FEV1 as well as FEV1pred in moderate-to-severe COPD but not mild COPD, which indicated the different status of TB in different COPD severity and the possible role as potential biomarker merely in moderate-to-severe COPD. Future researches to determine whether TB could be served as biomarker for COPD and the mechanisms should be focused on some target patients with a certain disease severity.Keywords: total bilirubin, COPD, lung function, GOLD stage, decline

Published
2022

20. Inhibition of miRNA-1-Mediated Inflammation and Autophagy by Astragaloside IV Improves Lipopolysaccharide-Induced Cardiac Dysfunction in Rats

Author

Wang Q, Chen W, Yang X, Song Y, Sun X, Tao G, Wang H, Zhao N, Huang Y, Chai E, and Tang F

Subjects
lipopolysaccharides, astragaloside iv, cardiac dysfunction, inflammation, autophagy, mirna-1, Pathology, RB1-214, Therapeutics. Pharmacology, RM1-950
Abstract

Qiuning Wang,1,&ast; Weiying Chen,2,&ast; Xuefeng Yang,3 Ying Song,4 Xiaowei Sun,5 Guizhou Tao,6 Hong Wang,7 Nan Zhao,7 Yue Huang,1 Erqing Chai,8 Futian Tang9 1Department of Pharmacology, Jinzhou Medical University, Jinzhou, Liaoning Province, People’s Republic of China; 2Department of Drug Quality Analysis, Jiuquan Drug Inspection and Testing Center, Jiuquan, Gansu Province, People’s Republic of China; 3Department of Physiology, Jinzhou Medical University, Jinzhou, Liaoning Province, People’s Republic of China; 4Cardiovascular Laboratory, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning Province, People’s Republic of China; 5Department of Neurosurgery, China Resources Liaojian Group, General Hospital of Fuxin Mining Group (10th Clinical College of China Medical University), Fuxin, Liaoning Province, People’s Republic of China; 6Internal Medicine-Cardiovascular Department, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning Province, People’s Republic of China; 7Allergy and Clinical Immunology Center, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning Province, People’s Republic of China; 8Neurointerventional Department, Emergency General Hospital, Beijing, People’s Republic of China; 9Department of Cardiovascular Disease and Key Laboratory of Digestive System Tumor of Gansu Province, Lanzhou University Second Hospital, Lanzhou, Gansu Province, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Futian Tang, Department of Cardiovascular Disease and Key Laboratory of Digestive System Tumor of Gansu Province, Lanzhou University Second Hospital, Lanzhou, Gansu Province, People’s Republic of China, Email tangft@163.com Erqing Chai, Neurointerventional Department, Emergency General Hospital, Beijing, People’s Republic of China, Email happybirds998@126.comIntroduction: Astragaloside IV (AS-IV) is one of the main active components isolated from the traditional Chinese medicinal herb, Astragalus membranaceus. The present study was designed to investigate whether the regulation of microRNA-1 (miR-1)-mediated inflammation and autophagy contributes to the protective effect of AS-IV against cardiac dysfunction in rats treated with lipopolysaccharides (LPS).Methods: Animal model of cardiac dysfunction in rats or cellular model of injured H9c2 heart cell line was established by using LPS. Echocardiography, electron microscopy, enzyme-linked immunosorbent assay, immunofluorescence, quantitative RT-PCR, and Western blotting were used to determine the cardiac function and expression of inflammation- and autophagy-related proteins at both the mRNA and protein levels.Results: LPS caused cardiac dysfunction in rats or injury in H9c2 cells and induced inflammation and autophagy. Compared with LPS treatment, AS-IV treatment attenuated cardiac dysfunction or cell injury, accompanied by inhibition of inflammation and autophagy. However, the miR-1 mimics partly abolished the effects of AS-IV. In addition, the effect of the miR-1 inhibitor was similar to that of AS-IV in the LPS model. Further analyses showed that AS-IV treatment decreased the mRNA expression of miR-1 in the heart tissue of rats and H9c2 cells treated with LPS.Conclusion: These results suggest that AS-IV attenuated cardiac dysfunction caused by LPS by inhibiting miR-1-mediated inflammation and autophagy, thereby providing a novel mechanism for the protection against cardiac diseases.Keywords: lipopolysaccharides, astragaloside IV, cardiac dysfunction, inflammation, autophagy, miRNA-1

Published
2022

21. Association Between Serum Total Bilirubin and COPD: Results from a Cross-Sectional Study and a Bidirectional Mendelian Randomization Analysis

Author

Dai C, Wang Z, Yang H, Xiao S, Xu J, Deng Z, Wu F, Wen X, Zheng Y, Lu L, Zhao N, Huang P, Zhou Y, and Ran P

Subjects
total bilirubin, copd, airflow limitation, mendelian randomization analysis, Infectious and parasitic diseases, RC109-216
Abstract

Cuiqiong Dai,1,&ast; Zihui Wang,1,&ast; Huajing Yang,1,&ast; Shan Xiao,1 Jianwu Xu,1 Zhishan Deng,1 Fan Wu,1,2 Xiang Wen,1 Youlan Zheng,1 Lifei Lu,1 Ningning Zhao,1 Peiyu Huang,1 Yumin Zhou,1,2 Pixin Ran1,2 1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, People’s Republic of China; 2Guangzhou Laboratory, Bio-Island, Guangzhou, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Pixin Ran; Yumin Zhou, Tel +86-20 3710 3616, Fax +86-20 81340482, Email pxran@gzhmu.edu.cn; zhouyumin410@126.comBackground: The potential protective role of serum total bilirubin (TB) for chronic obstructive pulmonary disease (COPD) is controversial. We aimed to investigate whether serum TB could prevent airflow limitation (reduce the risk of COPD) and whether these associations were causal or reversely causal.Methods: We conducted a multi-center and cross-sectional study including 3069 participants. Logistic regression model (LRM) with restricted cubic spline (RCS) and priori defined quintile categories were used to assess the associations of TB with COPD. Besides, ordinary least squares (OLS) regression model with RCS curves were applied to assess the dose-response relationship between serum TB and airflow limitation (FEV1/FVC). To verify the causal direction between TB and COPD, a bidirectional Mendelian randomization analysis was carried out with GWAS data from European ancestry.Results: In the cross-sectional study, the relationship between levels of TB and COPD risk was U shaped (P=0.001), and the low and high concentrations of TB apparently increasing the risk of COPD (OR 1.40, 95% CI 1.07 to 1.82 for less than 9 μmol/L; OR 1.36, 95% CI 1.06 to 1.76 for 9.01– 1 0.88 μmol/L; OR 1.50, 95% CI 1.16 to 1.95 for more than 13 μmol/L). There was a significant non-linear relationship between TB and FEV1/FVC (non-linear p=0.004). Furthermore, results of bidirectional Mendelian randomization analysis (OR 1.000; 95% CI 0.983 to 1.017 for MR and OR 0.998; 95% CI 0.976 to 1.020 for reversal MR) did not support the causal effects between serum TB and FEV1/FVC after controlling the effect of potential confounders and revised causality.Conclusion: Our study reveals that there was non-linear does-response pattern between serum TB and COPD. However, there was little evidence for the linear causal associations of serum TB with airflow limitation. The relationship of TB with COPD needs further study and careful interpretation.Keywords: total bilirubin, COPD, airflow limitation, Mendelian randomization analysis

Published
2022

22. Standard-Intensity Induction and Intermediate/High-Dose Cytarabine Consolidation Can Improve Survival for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Cohort Study

Author

Wang L, Zhao N, Zhou L, Tong J, Xue L, Zhang L, Han Y, Wang X, Geng L, Tang B, Liu H, Zhu W, Cai X, Liu X, Zhu X, Sun Z, and Zheng C

Subjects
acute myeloid leukemia, elderly patients, minimal residual disease, standard-intensity chemotherapy, intermediate or high dose cytarabine., Geriatrics, RC952-954.6
Abstract

Li Wang, Na Zhao, Li Zhou, Juan Tong, Lei Xue, Lei Zhang, Yongsheng Han, Xingbing Wang, Liangquan Geng, Baolin Tang, Huilan Liu, Weibo Zhu, Xiaoyan Cai, Xin Liu, Xiaoyu Zhu, Zimin Sun, Changcheng Zheng Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People’s Republic of ChinaCorrespondence: Changcheng ZhengDepartment of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Lujiang Road No. 17, Hefei, 230001, People’s Republic of ChinaTel/Fax +86-551-62284476Email zhengchch1123@ustc.edu.cnBackground: There is great uncertainty in the treatment of elderly patients with acute myeloid leukemia (AML), which leads to great challenges in treatment decision. The aim of this study is to find more suitable induction therapy and consolidation therapy for elderly AML patients.Methods: A total of 149 consecutive newly diagnosed elderly AML patients (aged ≥ 60 years) who received induction chemotherapy in our medical center from January 2015 to December 2019 were retrospectively analyzed.Results: After the first induction treatment, the complete remission/or complete remission with incomplete hematologic recovery (CR/CRi) rates in the standard-intensity chemotherapy group was significantly higher than that in the low-intensity chemotherapy group (58.2% vs 32.9%, p = 0.003). Compared with the low-intensity chemotherapy, the incidence of severe infection in the standard-intensity chemotherapy was significantly increased (p < 0.001), but the early mortality was comparable. One hundred and seven patients received minimal residual disease (MRD) examination after the first induction treatment; and MRD was negative accounting for 51.9% in the standard-intensity chemotherapy group, while only 32.7% in the low-intensity group (p = 0.05). The 2-year-overall survival (OS) of patients in standard-intensity induction chemotherapy group (37.2%) was slightly higher than that in low-intensity induction chemotherapy group (23.4%) (p = 0.075). Eighty-one CR/CRi patients received intermediate or high dose cytarabine (n = 35) or sequential chemotherapy regimens (n = 46) as consolidation treatment. The 2-year OS and event-free survival (EFS) of patients in the intermediate or high-dose cytarabine group were significantly higher than those in the sequential chemotherapy regimens group (73.0% vs 38.5%, p = 0.002; 54.8% vs 35.0%, p = 0.035).Conclusion: Our results showed that standard-intensity induction chemotherapy can significantly improve the CR rate for elderly AML patients, and does not increase the early mortality; consolidation therapy with intermediate or high-dose cytarabine can significantly improve EFS and OS for elderly AML patients achieved CR.Keywords: acute myeloid leukemia, elderly patients, minimal residual disease, standard-intensity chemotherapy, intermediate or high dose cytarabine

Published
2022

23. The Detection of Thyroid Nodules in Prediabetes Population and Analysis of Related Factors

Author

Chang X, Wang Y, Fu S, Tang X, Liu J, Zhao N, Jing G, Niu Q, Ma L, Teng W, and Shan Z

Subjects
prediabetes, thyroid nodules, risk factors, Public aspects of medicine, RA1-1270
Abstract

Xingyu Chang,1,2,&ast; Yaqi Wang,1,2,&ast; Songbo Fu,1,2 Xulei Tang,1,2 Jingfang Liu,1,2 Nan Zhao,1,2 Gaojing Jing,1,2 Qianglong Niu,1,2 Lihua Ma,1,2 Weiping Teng,3 Zhongyan Shan3 1Department of Endocrinology, First Hospital of Lanzhou University, Lanzhou, Gansu, 730000, People’s Republic of China; 2Gansu Provincial Endocrine Disease Clinical Medicine Research Center, Gansu, 730000, People’s Republic of China; 3Department of Endocrinology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, 101100, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Songbo FuDepartment of Endocrinology, First Hospital of Lanzhou University, Lanzhou, Gansu, 730000, People’s Republic of ChinaTel +86-13993122257Email fusb@lzu.edu.cnPurpose: To explore the detection of thyroid nodules (TN) and related influencing factors in the population of prediabetes (PreDM) in northwest China’s Gansu Province.Materials and Methods: A multi-stage stratified cluster random sampling method was used to select adult Han residents in Gansu Province for investigation, and recorded the clinical data of the subjects. The χ2 test was used to analyze the difference in TN detection rate of the PreDM population. Logistic regression analyzed the risk factors of TN in the PreDM population.Results: This study included 2659 people with normal glucose tolerance (NGT) and PreDM, of which 440 people were detected with TN. Among the PreDM population, the TN detection rate was higher than in the NGT population (24.48% vs 15.00%; P< 0.05). The detection rate of TN in the impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and IFG+IGT group was also significantly higher than that in the NGT population (X2=4.117, X2=13.187, X2=13.016, all P< 0.05), and of which, the IFG+IGT group was the highest (32.20%). The general trend of TN in the IFG, IGT and PreDM population all increased with age. General data showed that BMI, waist-to-height ratio, waist circumference, TG, TC, LDL-C, FPG, 2h PG, HbA1c and TSH indicators in the TN group were higher than those in the Non-TN group (P< 0.05). The logistic regression suggested that the risk factors for TN in the PreDM population were female, age increase, high SP, high TSH, high FPG, high LDL-C, hypertension and family history of diabetes (all P< 0.05).Conclusion: The detection rate of TN in the PreDM population is high, especially in the IFG+IGT population. Middle-aged and elderly people with hypertension and abnormal glucose and lipid metabolism should be treated reasonably and regularly, and their TN should be screened and followed up.Keywords: prediabetes, thyroid nodules, risk factors

Published
2021

24. Association of Total Airway Count on Computed Tomography with Pulmonary Function Decline in Early-Stage COPD: A Population-Based Prospective Cohort Study

Author

Wu F, Jiang C, Zhou Y, Zheng Y, Tian H, Li H, Deng Z, Zhao N, Chen H, and Ran P

Subjects
chronic obstructive pulmonary disease, copd, computed tomography, total airway count, tac, Diseases of the respiratory system, RC705-779
Abstract

Fan Wu,1,2,&ast; Changbin Jiang,1,&ast; Yumin Zhou,1,2,&ast; Youlan Zheng,1,&ast; Heshen Tian,1 Haiqing Li,1 Zhishan Deng,1 Ningning Zhao,1 Huai Chen,3 Pixin Ran1,2 1National Center for Respiratory Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of China; 2Guangzhou Laboratory, Bio-island, Guangzhou, People’s Republic of China; 3Department of Radiology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Pixin RanNational Center for Respiratory Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of ChinaTel +86 20 83205187Fax +86 20-81340482Email pxran@gzhmu.edu.cnBackground: It has been found that the degree of terminal bronchiole destruction is associated with the severity of COPD. However, total airway count (TAC) of CT-visible and its relationship with COPD lung function severity and pulmonary function decline remains controversial. The present study aimed to determine whether TAC is significantly reduced in early-stage COPD (GOLD stage I–II) compared with healthy control subjects and whether TAC is associated with annual decline in pulmonary function in Chinese patients with early-stage COPD.Methods: A total of 176 participants were enrolled in this study, of which 139 participants had undergone at least two spirometry measurements within 7 years (average 5.5 [standard deviation 0.8] years) after baseline data acquisition. CT-visible TAC was measured by summing all airway segments using semi-automated software. Average lumen diameter, average inner area, emphysema index, air trapping, and inspiratory Pi10 were also measured. Multivariable linear analysis was performed to evaluate variables that were significantly related to pulmonary function parameters and to evaluate the correlation between TAC and annual decline in longitudinal pulmonary function.Results: Compared with healthy control subjects, CT-visible TAC was significantly reduced by 51% in GOLD II and by 31% in GOLD I after adjustment. TAC had the greatest impact on pre-bronchodilator FEV1, pre-bronchodilator FVC, post-bronchodilator FEV1, and post-bronchodilator FEV1/FVC (both p< 0.001) among all CT indicators measured. TAC has the best correlation with inspiratory Pi10 (ρ=− 0.751, p< 0.001), an evaluation indicator of the degree of airway remodeling. TAC was independently associated with annual decline in pre-bronchodilator FEV1 (p=0.023), post-bronchodilator FEV1 (p=0.018), and post-bronchodilator FEV1/FVC (p< 0.001).Conclusion: This finding suggests that CT-visible TAC may be an evaluation indicator of the degree of airway remodeling, and was diminished in greater COPD lung function severity, and independently associated with disease progression. Early-stage COPD patients have already occurred lung structural changes and early intervention may be needed to ameliorate the progression of disease.Clinical Trial Registration: ChiCTR-OO-14004264.Keywords: chronic obstructive pulmonary disease, COPD, computed tomography, total airway count, TAC

Published
2021

25. Measurement of cross sections of $e^+e^-\to K^0_S K^0_S \psi(3686)$ from $\sqrt{s}=$ 4.682 to 4.951 GeV

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., An, Q., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chai, X. Y., Chang, J. F., Che, G. R., Che, Y. Z., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, G. F., Fan, J. J., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, Q. P., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, P., Huang, X. T., Huang, Y. P., Huang, Y. S., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lan, W. N., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, K. L., Li, L. J., Li, Lei, Li, M. H., Li, P. L., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, T., Li, T. Y., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, C. X., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, L. R., Ma, Q. M., Ma, R. Q., Ma, R. Y., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y. M., Maas, F. E., MacKay, I., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Y. H., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pathak, A., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H. R., Qi, M., Qian, S., Qian, W. B., Qiao, C. F., Qiao, J. H., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. P., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, M. Q., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, J. L., Shi, J. Y., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, S. S, Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tat, M., Teng, J. X., Thoren, V., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, Bo, Wang, C., Wang, D. Y., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, L. W., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. H., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, Lianjie, Wu, X., Wu, X. H., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, H., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W. L., Xu, X. P., Xu, Y., Xu, Y. C., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, W. P., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, J. H., Yang, R. J., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Y. Z., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, Junhao, You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, M. C., Yu, T., Yu, X. D., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Yue, Ying, Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. M., Zhang, X. Y, Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. X., Zhang, Z. Y., Zhang, Z. Z., Zhang, Zh. Zh., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, X. R., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, H., Zhou, J. Y., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhou, Z. C., Zhu, A. N., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, T. J., Zhu, W. D., Zhu, W. J., Zhu, W. Z., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment
Abstract

The process $e^+e^-\to K^0_S K^0_S \psi(3686)$ is studied by analyzing $e^+e^-$ collision data samples collected at eight center-of-mass energies ranging from 4.682 to 4.951 GeV with the BESIII detector operating at the BEPCII collider, corresponding to an integrated luminosity of $4.1~{\rm fb}^{-1}$. Observation of the $e^+e^-\to K^0_S K^0_S \psi(3686)$ process is found for the first time with a statistical significance of $6.3\sigma$, and the cross sections at each center-of-mass energy are measured. The ratio of cross sections of $e^+e^-\to K_S^0 K_S^0 \psi(3686)$ relative to $e^+e^-\to K^+ K^- \psi(3686)$ is determined to be $\frac{\sigma(e^+e^-\to K_S^0 K_S^0 \psi(3686))}{\sigma(e^+e^-\to K^+ K^- \psi(3686))}=0.45 \pm 0.25$, which is consistent with the prediction based on isospin symmetry. The uncertainty includes both statistical and systematic contributions. Additionally, the $K_S^0\psi(3686)$ invariant mass distribution is found to be consistent with three-body phase space. The significance of a contribution beyond three-body phase space is only $0.8\sigma$.

Published
2024

26. Evidence for Two Excited $\Omega^{-}$ Hyperons

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chai, X. Y., Chang, J. F., Che, G. R., Che, Y. Z., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Chen, Z. Y., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, L., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, Q. P., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, X. T., Huang, Y. P., Huang, Y. S., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Jeong, J. H., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lavezzi, L., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, K. L., Li, L. J., Li, L. K., Li, Lei, Li, M. H., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, S. X., Li, T., Li, T. Y., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, C. X., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, J. Y., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, X. L., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, L. R., Ma, M. M., Ma, Q. M., Ma, R. Q., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y. M., Maas, F. E., MacKay, I., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Y. H., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pathak, A., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H., Qi, H. R., Qi, M., Qi, T. Y., Qian, S., Qian, W. B., Qiao, C. F., Qiao, X. K., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. P., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, M. Q., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, J. L., Shi, J. Y., Shi, Q. Q., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, S. S, Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, W. Y., Sun, Y., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tao, Q. T., Tat, M., Teng, J. X., Thoren, V., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, B. L., Wang, Bo, Wang, D. Y., Wang, F., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. H., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wang, Ziyi, Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, X., Wu, X. H., Wu, Y., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, H., Xiao, S. Y., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, H. Y., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W., Xu, W. L., Xu, X. P., Xu, Y., Xu, Y. C., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, J. H., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, J. H., Yin, Junhao, You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, M. C., Yu, T., Yu, X. D., Yu, Y. C., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. M., Zhang, X. Y, Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. Y., Zhang, Z. Z., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, H., Zhou, J. Y., Zhou, L. P., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhou, Z. C., Zhu, A. N., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, T. J., Zhu, W. D., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment, High Energy Physics - Phenomenology
Abstract

Using $e^+e^-$ collision data corresponding to an integrated luminosity of 19 fb$^{-1}$ collected by the BESIII detector at center-of-mass energies ranging from 4.13 to 4.70 GeV, we report the first evidence for a new excited $\Omega^{-}$ hyperon, the $\Omega^*(2109)^{-}$, through the process $e^+ e^- \to \Omega^*(2109)^{-} \bar{\Omega}^{+} +c.c.$ with a significance of 3.7 $\sigma$. The mass and width of $\Omega^*(2109)^{-}$ are measured to be $2108.8 \pm 5.5_{\rm stat} \pm 1.5_{\rm syst} {\rm MeV}/c^{2}$ and $21.6 \pm 17.7_{\rm stat} \pm 9.4_{\rm syst} {\rm MeV}$, respectively. We also present evidence for production of the $\Omega^*(2012)^{-}$ in the process $e^+ e^- \to \Omega^*(2012)^{-} \bar{\Omega}^{+} +c.c.$ with a significance of 3.7 $\sigma$., Comment: 8 pages, 2 figures

Published
2024

27. Study of the light scalar $a_{0}(980)$ through the decay $D^{0} \to a_{0}(980)^-e^{+} \nu_{e}$ with $a_{0}(980)^- \to \eta \pi^-$

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., An, Q., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chai, X. Y., Chang, J. F., Che, G. R., Che, Y. Z., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Chen, Z. Y., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, L., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, Q. P., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, X. T., Huang, Y. P., Huang, Y. S., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Jeong, J. H., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lavezzi, L., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, K. L., Li, L. J., Li, L. K., Li, Lei, Li, M. H., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, S. X., Li, T., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, C. X., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, J. Y., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, X. L., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, L. R., Ma, M. M., Ma, Q. M., Ma, R. Q., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y. M., Maas, F. E., MacKay, I., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pathak, A., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H., Qi, H. R., Qi, M., Qi, T. Y., Qian, S., Qian, W. B., Qiao, C. F., Qiao, X. K., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. P., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, M. Q., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, H. C., Shi, J. L., Shi, J. Y., Shi, Q. Q., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, S. S, Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, W. Y., Sun, Y., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tao, Q. T., Tat, M., Teng, J. X., Thoren, V., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, B. L., Wang, Bo, Wang, D. Y., Wang, F., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. H., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wang, Ziyi, Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, X., Wu, X. H., Wu, Y., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, S. Y., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, H. Y., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W., Xu, W. L., Xu, X. P., Xu, Y., Xu, Y. C., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, J. H., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, J. H., Yin, Junhao, You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, M. C., Yu, T., Yu, X. D., Yu, Y. C., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. M., Zhang, X. Y, Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. Y., Zhang, Z. Z., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, H., Zhou, J. Y., Zhou, L. P., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhou, Z. C., Zhu, A. N., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, T. J., Zhu, W. D., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment
Abstract

Using 7.93 ${\rm fb^{-1}}$ of $e^+e^-$ collision data collected at a center-of-mass energy of 3.773 ${\rm GeV}$ with the BESIII detector, we present an analysis of the decay $D^{0} \to \eta \pi^- e^+ \nu_{e}$. The branching fraction of the decay $D^{0} \to a_{0}(980)^{-} e^+ \nu_{e}$ with $a_{0}(980)^{-} \to \eta \pi^{-}$ is measured to be $(0.86\pm0.17_{\text{stat}}\pm0.05_{\text{syst}})\times 10^{-4}$. The decay dynamics of this process is studied with a single-pole parameterization of the hadronic form factor and the Flatt\'e formula describing the $a_0(980)$ line shape in the differential decay rate. The product of the form factor $f^{ a_0}_{+}(0)$ and the Cabibbo-Kobayashi-Maskawa matrix element $|V_{cd}|$ is determined for the first time with the result $f^{ a_0}_+(0)|V_{cd}|=0.126\pm0.013_{\rm stat}\pm0.003_{\rm syst}$.

Published
2024

28. Search for $\Lambda$-$\bar{\Lambda} $ oscillation in $J/\psi\rightarrow\Lambda\bar{\Lambda}$ decay

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., An, Q., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chang, J. F., Che, G. R., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Chen, Z. Y., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, L., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, X. T., Huang, Y. P., Huang, Y. S., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Jeong, J. H., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lane, J. J., Lavezzi, L., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, L. J., Li, L. K., Li, Lei, Li, M. H., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, S. X., Li, T., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, J. Y., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, X. L., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, L. R., Ma, M. M., Ma, Q. M., Ma, R. Q., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y., Ma, Y. M., Maas, F. E., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pathak, A., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H., Qi, H. R., Qi, M., Qi, T. Y., Qian, S., Qian, W. B., Qiao, C. F., Qiao, X. K., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. P., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, H. C., Shi, J. L., Shi, J. Y., Shi, Q. Q., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, W. Y., Sun, Y., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tao, Q. T., Tat, M., Teng, J. X., Thoren, V., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, B. L., Wang, Bo, Wang, D. Y., Wang, F., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wang, Ziyi, Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, X., Wu, X. H., Wu, Y., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, S. Y., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, H. Y., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W., Xu, W. L., Xu, X. P., Xu, Y. C., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, J. H., Yin, Junhao, You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, T., Yu, X. D., Yu, Y. C., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. D., Zhang, X. M., Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. Y., Zhang, Z. Z., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, H., Zhou, J. Y., Zhou, L. P., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhu, A. N., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, T. J., Zhu, W. D., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment
Abstract

Using $(10087\pm44)\times 10^{6}$ $J/\psi$ decays collected by the BESIII detector at the BEPCII collider, we search for baryon number violation via $\Lambda-\bar{\Lambda}$ oscillation in the decay $J/\psi \to \Lambda \bar{\Lambda}$. No evidence for $\Lambda-\bar\Lambda$ oscillation is observed. The upper limit on the time-integrated probability of $\Lambda-\bar{\Lambda}$ oscillation is estimated to be $1.4\times 10^{-6}$, corresponding to an oscillation parameter less than $2.1\times 10^{-18}~\mathrm{GeV}$ at $90\%$ confidence level., Comment: 8 pages, 2 figures

Published
2024

29. Measurement of the branching fraction of $D^+ \to \tau^+\nu_{\tau}$

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., An, Q., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chai, X. Y., Chang, J. F., Che, G. R., Che, Y. Z., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Chen, Z. Y., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, L., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, Q. P., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, X. T., Huang, Y. P., Huang, Y. S., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lavezzi, L., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, K. L., Li, L. J., Li, L. K., Li, Lei, Li, M. H., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, S. X., Li, T., Li, T. Y., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, C. X., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, J. Y., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, X. L., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, L. R., Ma, M. M., Ma, Q. M., Ma, R. Q., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y. M., Maas, F. E., MacKay, I., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H., Qi, H. R., Qi, M., Qi, T. Y., Qian, S., Qian, W. B., Qiao, C. F., Qiao, J. H., Qiao, X. K., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. P., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, M. Q., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, J. L., Shi, J. Y., Shi, Q. Q., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, S. S, Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, W. Y., Sun, Y., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tao, Q. T., Tat, M., Teng, J. X., Tian, J. Y., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, B. L., Wang, Bo, Wang, D. Y., Wang, F., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, L. W., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. H., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wang, Ziyi, Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, X., Wu, X. H., Wu, Y., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, S. Y., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, H. Y., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W., Xu, W. L., Xu, X. P., Xu, Y., Xu, Y. C., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, J. H., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, J. H., Yin, Junhao, You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, M. C., Yu, T., Yu, X. D., Yu, Y. C., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. M., Zhang, X. Y, Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. Y., Zhang, Z. Z., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, H., Zhou, J. Y., Zhou, L. P., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhou, Z. C., Zhu, A. N., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, T. J., Zhu, W. D., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment
Abstract

By analyzing $e^{+}e^{-}$ collision data with an integrated luminosity of 7.9~fb$^{-1}$ collected with the BESIII detector at the center-of-mass energy of 3.773~GeV, the branching fraction of $D^+\to\tau^+\nu_{\tau}$ is determined as $\mathcal{B}=(9.9\pm 1.1_\mathrm{stat}\pm 0.5_\mathrm{syst})\times10^{-4}$. Taking the most precise result $\mathcal{B}(D^+\to\mu^+\nu_{\mu})=(3.981\pm 0.079_\mathrm{stat}\pm0.040_\mathrm{syst})\times10^{-4}$, we determine $R_{\tau/\mu} = \Gamma(D^+\to\tau^+\nu_{\tau})/\Gamma(D^+\to\mu^+\nu_{\mu})= 2.49\pm0.31$, achieving a factor of two improvement in precision compared to the previous BESIII result. This measurement is in agreement with the standard model prediction of lepton flavor universality within one standard deviation.

Published
2024

30. Search for $\eta_c(2S)\to p\bar{p}$ and branching fraction measurements of $\chi_{cJ} \to p\bar{p}$ via $\psi(2S)$ radiative decays

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chai, X. Y., Chang, J. F., Che, G. R., Che, Y. Z., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De~Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, G. F., Fan, J. J., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, Q. P., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, P., Huang, X. T., Huang, Y. P., Huang, Y. S., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lan, W. N., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, K. L., Li, L. J., Li, Lei, Li, M. H., Li, P. L., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, T., Li, T. Y., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, C. X., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, L. R., Ma, Q. M., Ma, R. Q., Ma, R. Y., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y. M., Maas, F. E., MacKay, I., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Y. H., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pathak, A., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H. R., Qi, M., Qian, S., Qian, W. B., Qiao, C. F., Qiao, J. H., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. P., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, M. Q., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, J. L., Shi, J. Y., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, S. S, Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tat, M., Teng, J. X., Thoren, V., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, Bo, Wang, C., Wang, D. Y., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, L. W., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. H., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, Lianjie, Wu, X., Wu, X. H., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, H., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W. L., Xu, X. P., Xu, Y., Xu, Y. C., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, W. P., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, J. H., Yang, R. J., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Y. Z., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, Junhao, You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, M. C., Yu, T., Yu, X. D., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Yue, Ying, Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. M., Zhang, X. Y, Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. X., Zhang, Z. Y., Zhang, Z. Z., Zhang, Zh. Zh., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, X. R., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, H., Zhou, J. Y., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhou, Z. C., Zhu, A. N., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, T. J., Zhu, W. D., Zhu, W. Z., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment
Abstract

Using $(27.12\pm0.14) \times 10^{8}$ $\psi(2S)$ events collected by the BESIII detector operating at BEPCII, we search for the decay $\eta_c(2S)\to p\bar{p}$ via the process $\psi(2S)\to \gamma\eta_c(2S)$, and only find a signal with a significance of $1.7\,\sigma$. The upper limit of the product branching fraction at the 90% confidence level is determined to be $\mathcal{B}(\psi(2S)\to \gamma\eta_c(2S))\times \mathcal{B}(\eta_c(2S)\to p\bar{p})<2.4\times 10^{-7}$. The branching fractions of $\chi_{cJ}\to p\bar{p}~(J=0,1,2)$ are also measured to be $\mathcal{B}(\chi_{c0}\to p\bar{p})=(2.51\pm0.02\pm0.08)\times 10^{-4}$, $\mathcal{B}(\chi_{c1}\to p\bar{p})=(8.16\pm0.09\pm0.25)\times 10^{-4}$, and $\mathcal{B}(\chi_{c2}\to p\bar{p})=(8.33\pm0.09\pm0.22)\times 10^{-4}$, where the first uncertainty is statistical and the second systematic.

Published
2024

31. Measurement of the branching fractions of the decays $\Lambda_{c}^{+}\rightarrow\Lambda K_{S}^{0}K^{+}$, $\Lambda_{c}^{+}\rightarrow\Lambda K_{S}^{0}\pi^{+}$ and $\Lambda_{c}^{+}\rightarrow\Lambda K^{*+}$

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., An, Q., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chang, J. F., Che, G. R., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Chen, Z. Y., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, L., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, X. T., Huang, Y. P., Huang, Y. S., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Jeong, J. H., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lane, J. J., Larin, P., Lavezzi, L., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, L. J., Li, L. K., Li, Lei, Li, M. H., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, S. X., Li, T., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, L. Z., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, J. Y., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, X. L., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, M. M., Ma, Q. M., Ma, R. Q., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y., Ma, Y. M., Maas, F. E., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pathak, A., Patteri, P., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H., Qi, H. R., Qi, M., Qi, T. Y., Qian, S., Qian, W. B., Qiao, C. F., Qiao, X. K., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. P., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, H. C., Shi, J. L., Shi, J. Y., Shi, Q. Q., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, W. Y., Sun, Y., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tao, Q. T., Tat, M., Teng, J. X., Thoren, V., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, B. L., Wang, Bo, Wang, D. Y., Wang, F., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wang, Ziyi, Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, X., Wu, X. H., Wu, Y., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, S. Y., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, H. Y., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W., Xu, W. L., Xu, X. P., Xu, Y. C., Xu, Z. P., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, J. H., You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, T., Yu, X. D., Yu, Y. C., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. D., Zhang, X. M., Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. Y., Zhang, Z. Z., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, H., Zhou, J. Y., Zhou, L. P., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, S. Q., Zhu, T. J., Zhu, W. D., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment
Abstract

Studies are performed of the Cabibbo-favored decay $\Lambda_{c}^{+}\to\Lambda K_{S}^{0}K^+$ and the singly Cabibbo-suppressed decay $\Lambda_{c}^{+}\to\Lambda K_{S}^{0}\pi^+$, based on a sample of $e^{+}e^{-}$ collision data, corresponding to an integrated luminosity of 4.5 fb$^{-1}$, accumulated at center-of-mass energies between $4599.53$ MeV and $4698.82$ MeV with the BESIII detector. The decay $\Lambda_{c}^{+}\to\Lambda K_{S}^{0}\pi^+$ is observed for the first time. The branching fractions of $\Lambda_{c}^{+}\to\Lambda K_{S}^{0}K^+$ and $\Lambda_{c}^{+}\to\Lambda K_{S}^{0}\pi^+$ are measured to be $(3.04\pm0.30\pm0.16)\times 10^{-3}$ and $(1.73\pm0.27\pm0.10)\times 10^{-3}$, respectively, where the first uncertainties are statistical and the second are systematic. These results correspond to the most precise measurement of these quantities for both decays. Evidence of a $K^{*+}$ contribution in the $\Lambda_{c}^{+}\to\Lambda K_{S}^{0}\pi^+$ decay is found with a statistical significance of $4.7\sigma$. The branching fraction of $\Lambda_{c}^{+}\to\Lambda K^{*+}$ is calculated under three possible interference scenarios.

Published
2024

32. Observation of a rare beta decay of the charmed baryon with a Graph Neural Network

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., An, Q., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chang, J. F., Che, G. R., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Chen, Z. Y., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, L., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, X. T., Huang, Y. P., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Jeong, J. H., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lane, J. J., Larin, P., Lavezzi, L., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, L. J., Li, L. K., Li, Lei, Li, M. H., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, S. X., Li, T., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, L. Z., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, J. Y., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, X. L., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, M. M., Ma, Q. M., Ma, R. Q., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y., Ma, Y. M., Maas, F. E., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pathak, A., Patteri, P., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H., Qi, H. R., Qi, M., Qi, T. Y., Qian, S., Qian, W. B., Qiao, C. F., Qiao, X. K., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, H. C., Shi, J. L., Shi, J. Y., Shi, Q. Q., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, W. Y., Sun, Y., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tao, Q. T., Tat, M., Teng, J. X., Thoren, V., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, B. L., Wang, Bo, Wang, D. Y., Wang, F., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wang, Ziyi, Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, X., Wu, X. H., Wu, Y., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, S. Y., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, H. Y., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W., Xu, W. L., Xu, X. P., Xu, Y. C., Xu, Z. P., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, J. H., You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, T., Yu, X. D., Yu, Y. C., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. D., Zhang, X. M., Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. Y., Zhang, Z. Z., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, H., Zhou, J. Y., Zhou, L. P., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, S. Q., Zhu, T. J., Zhu, W. D., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment, High Energy Physics - Lattice, High Energy Physics - Phenomenology, Nuclear Experiment
Abstract

The study of beta decay of the charmed baryon provides unique insights into the fundamental mechanism of the strong and electro-weak interactions. The $\Lambda_c^+$, being the lightest charmed baryon, undergoes disintegration solely through the charm quark weak decay. Its beta decay provides an ideal laboratory for investigating non-perturbative effects in quantum chromodynamics and for constraining the fundamental parameters of the Cabibbo-Kobayashi-Maskawa matrix in weak interaction theory. This article presents the first observation of the Cabibbo-suppressed $\Lambda_c^+$ beta decay into a neutron $\Lambda_c^+ \rightarrow n e^+ \nu_{e}$, based on $4.5~\mathrm{fb}^{-1}$ of electron-positron annihilation data collected with the BESIII detector in the energy region above the $\Lambda^+_c\bar{\Lambda}^-_c$ threshold. A novel machine learning technique, leveraging Graph Neural Networks, has been utilized to effectively separate signals from dominant backgrounds, particularly $\Lambda_c^+ \rightarrow \Lambda e^+ \nu_{e}$. This approach has yielded a statistical significance of more than $10\sigma$. The absolute branching fraction of $\Lambda_c^+ \rightarrow n e^+ \nu_{e}$ is measured to be $(3.57\pm0.34_{\mathrm{stat}}\pm0.14_{\mathrm{syst}})\times 10^{-3}$. For the first time, the CKM matrix element $\left|V_{cd}\right|$ is extracted via a charmed baryon decay to be $0.208\pm0.011_{\rm exp.}\pm0.007_{\rm LQCD}\pm0.001_{\tau_{\Lambda_c^+}}$. This study provides a new probe to further understand fundamental interactions in the charmed baryon sector, and demonstrates the power of modern machine learning techniques in enhancing experimental capability in high energy physics research., Comment: 28 pages, 6 figures

Published
2024

33. Observation of $\chi_{c0}\to\Sigma^{+}\bar{\Sigma}^{-}\eta$ and evidence for $\chi_{c1,2}\to\Sigma^{+}\bar{\Sigma}^{-}\eta$

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., An, Q., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chang, J. F., Che, G. R., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Chen, Z. Y., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, L., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, X. T., Huang, Y. P., Huang, Y. S., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Jeong, J. H., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lane, J. J., Lavezzi, L., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, L. J., Li, L. K., Li, Lei, Li, M. H., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, S. X., Li, T., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, J. Y., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, X. L., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, M. M., Ma, Q. M., Ma, R. Q., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y., Ma, Y. M., Maas, F. E., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pathak, A., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H., Qi, H. R., Qi, M., Qi, T. Y., Qian, S., Qian, W. B., Qiao, C. F., Qiao, X. K., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. P., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, H. C., Shi, J. L., Shi, J. Y., Shi, Q. Q., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, W. Y., Sun, Y., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tao, Q. T., Tat, M., Teng, J. X., Thoren, V., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, B. L., Wang, Bo, Wang, D. Y., Wang, F., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wang, Ziyi, Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, X., Wu, X. H., Wu, Y., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, S. Y., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, H. Y., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W., Xu, W. L., Xu, X. P., Xu, Y. C., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, J. H., You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, T., Yu, X. D., Yu, Y. C., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. D., Zhang, X. M., Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. Y., Zhang, Z. Z., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, H., Zhou, J. Y., Zhou, L. P., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, T. J., Zhu, W. D., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment
Abstract

Using $(27.12\pm 0.14)\times10^{8}$ $\psi(3686)$ events collected with the BESIII detector, the decay $\chi_{c0}\to\Sigma^{+}\bar{\Sigma}^{-}\eta$ is observed for the first time with a statistical significance of $7.0\sigma$, and evidence for $\chi_{c1}\to\Sigma^{+}\bar{\Sigma}^{-}\eta$ and $\chi_{c2}\to\Sigma^{+}\bar{\Sigma}^{-}\eta$ is found with statistical significances of $4.3\sigma$ and $4.6\sigma$, respectively. The branching fractions are determined to be $\mathcal{B}(\chi_{c0}\to\Sigma^{+}\bar{\Sigma}^{-}\eta)=({1.26 \pm 0.20 \pm 0.13}) \times 10^{-4}, ~\mathcal{B}(\chi_{c1}\to\Sigma^{+}\bar{\Sigma}^{-}\eta)=({5.10 \pm 1.21 \pm 0.67}) \times 10^{-5}$, and $\mathcal{B}(\chi_{c2}\to\Sigma^{+}\bar{\Sigma}^{-}\eta)=({5.46 \pm 1.18 \pm 0.50}) \times 10^{-5}$, where the first uncertainties are statistical, and the second ones are systematic.

Published
2024

34. Observation of the Singly Cabibbo-Suppressed Decay $\Lambda_c^{+}\to p\pi^0$

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., An, Q., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chang, J. F., Che, G. R., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Chen, Z. Y., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, L., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, X. T., Huang, Y. P., Huang, Y. S., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Jeong, J. H., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lane, J. J., Lavezzi, L., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, L. J., Li, L. K., Li, Lei, Li, M. H., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, S. X., Li, T., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, J. Y., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, X. L., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, L. R., Ma, M. M., Ma, Q. M., Ma, R. Q., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y., Ma, Y. M., Maas, F. E., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pathak, A., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H., Qi, H. R., Qi, M., Qi, T. Y., Qian, S., Qian, W. B., Qiao, C. F., Qiao, X. K., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. P., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, H. C., Shi, J. L., Shi, J. Y., Shi, Q. Q., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, W. Y., Sun, Y., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tao, Q. T., Tat, M., Teng, J. X., Thoren, V., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, B. L., Wang, Bo, Wang, D. Y., Wang, F., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wang, Ziyi, Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, X., Wu, X. H., Wu, Y., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, S. Y., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, H. Y., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W., Xu, W. L., Xu, X. P., Xu, Y. C., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, J. H., Yin, Junhao, You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, T., Yu, X. D., Yu, Y. C., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. D., Zhang, X. M., Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. Y., Zhang, Z. Z., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, H., Zhou, J. Y., Zhou, L. P., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhu, A. N., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, T. J., Zhu, W. D., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment, High Energy Physics - Phenomenology
Abstract

Utilizing 4.5${~\rm{fb}}^{-1}$ of $e^+e^-$ annihilation data collected with the BESIII detector at the BEPCII collider at center-of-mass energies between 4.600 and 4.699 GeV, the first observation of the singly Cabibbo-suppressed decay $\Lambda_c^{+}\to p\pi^0$ is presented, with a statistical significance of $5.4\sigma$. The ratio of the branching fractions of $\Lambda_c^{+}\to p\pi^0$ and $\Lambda_c^{+}\to p\eta$ is measured as $\mathcal{B}(\Lambda_c^{+}\to p\pi^0)/\mathcal{B}(\Lambda_c^{+}\to p\eta)=(0.120\pm0.026_{\rm stat.}\pm0.007_{\rm syst.})$. This result resolves the longstanding discrepancy between earlier experimental searches, providing both a decisive conclusion and valuable input for QCD-inspired theoretical models. A sophisticated deep learning approach using a Transformer-based architecture is employed to distinguish the signal from the prevalent hadronic backgrounds, complemented by thorough validation and systematic uncertainty quantification., Comment: 9 pages, 4 figures

Published
2024

35. Search for $e^{+}e^{-} \to \phi \chi_{c0}$ and $\phi\eta_{c2}(1D)$ at center-of-mass energies from 4.47 to 4.95 GeV

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., An, Q., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chang, J. F., Che, G. R., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Chen, Z. Y., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, L., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, X. T., Huang, Y. P., Huang, Y. S., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Jeong, J. H., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lane, J. J., Lavezzi, L., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, K. L., Li, L. J., Li, L. K., Li, Lei, Li, M. H., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, S. X., Li, T., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, J. Y., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, X. L., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, L. R., Ma, M. M., Ma, Q. M., Ma, R. Q., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y., Ma, Y. M., Maas, F. E., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pathak, A., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H., Qi, H. R., Qi, M., Qi, T. Y., Qian, S., Qian, W. B., Qiao, C. F., Qiao, X. K., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. P., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, H. C., Shi, J. L., Shi, J. Y., Shi, Q. Q., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, S. S, Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, W. Y., Sun, Y., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tao, Q. T., Tat, M., Teng, J. X., Thoren, V., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, B. L., Wang, Bo, Wang, D. Y., Wang, F., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wang, Ziyi, Wei, D., Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, X., Wu, X. H., Wu, Y., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, S. Y., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, H. Y., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W., Xu, W. L., Xu, X. P., Xu, Y., Xu, Y. C., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, J. H., Yin, Junhao, You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, M. C., Yu, T., Yu, X. D., Yu, Y. C., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. D., Zhang, X. M., Zhang, X. Y, Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. Y., Zhang, Z. Z., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, H., Zhou, J. Y., Zhou, L. P., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhou, Z. C., Zhu, A. N., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, T. J., Zhu, W. D., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment
Abstract

Utilizing a data set of $6.7$ fb$^{-1}$ from electron-positron collisions recorded by the BESIII detector at the BEPCII storage ring, a search is conducted for the processes $e^{+}e^{-} \to \phi \chi_{c0}$ and $\phi\eta_{c2}(1D)$ across center-of-mass energies from 4.47 to 4.95 GeV. In the absence of any significant signals, upper limits are set. These include limits on the Born cross sections for $e^{+}e^{-} \to \phi \chi_{c0}$, as well as the product of the Born cross section for $e^{+}e^{-} \to \phi\eta_{c2}(1D)$ and a sum of five branching fractions. Furthermore, the product of the electronic width of $Y(4660)$ and the branching fraction of the $Y(4660) \to \phi\chi_{c0}$, denoted as $\Gamma^{Y(4660)}_{e^{+}e^{-}} \mathcal{B}_{Y(4660) \to \phi\chi_{c0}}$, is determined to be $< 0.40$ eV at the 90\% confidence level., Comment: 14 pages, 6 figures

Published
2024

36. Observation of $\chi_{cJ}\to p \bar p K^0_S K^- \pi^+ + c.c.$

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chai, X. Y., Chang, J. F., Che, G. R., Che, Y. Z., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Chen, Z. Y., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, L., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, Q. P., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, X. T., Huang, Y. P., Huang, Y. S., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Jeong, J. H., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lavezzi, L., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, K. L., Li, L. J., Li, L. K., Li, Lei, Li, M. H., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, S. X., Li, T., Li, T. Y., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, C. X., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, J. Y., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, X. L., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, L. R., Ma, M. M., Ma, Q. M., Ma, R. Q., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y. M., Maas, F. E., MacKay, I., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pathak, A., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H., Qi, H. R., Qi, M., Qi, T. Y., Qian, S., Qian, W. B., Qiao, C. F., Qiao, X. K., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. P., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, M. Q., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, J. L., Shi, J. Y., Shi, Q. Q., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, S. S, Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, W. Y., Sun, Y., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tao, Q. T., Tat, M., Teng, J. X., Thoren, V., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, B. L., Wang, Bo, Wang, D. Y., Wang, F., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. H., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wang, Ziyi, Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, X., Wu, X. H., Wu, Y., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, S. Y., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, H. Y., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W., Xu, W. L., Xu, X. P., Xu, Y., Xu, Y. C., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, J. H., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, J. H., Yin, Junhao, You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, M. C., Yu, T., Yu, X. D., Yu, Y. C., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. M., Zhang, X. Y, Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. Y., Zhang, Z. Z., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, H., Zhou, J. Y., Zhou, L. P., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhou, Z. C., Zhu, A. N., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, T. J., Zhu, W. D., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment
Abstract

By analyzing $(27.12\pm0.14)\times10^8$ $\psi(3686)$ events collected with the BESIII detector operating at the BEPCII collider, the decays of $\chi_{cJ} \to p \bar{p} K^0_S K^- \pi^+ +c.c.(J=0, 1, 2)$ are observed for the first time with statistical significances greater than $10\sigma$. The branching fractions of these decays are determined to be $\mathcal{B}(\chi_{c0}\to p \bar p K^{0}_{S} K^- \pi^+ + c.c.)=(2.61\pm0.27\pm0.32)\times10^{-5},$ $\mathcal{B}(\chi_{c1}\to p \bar p K^{0}_{S} K^- \pi^+ + c.c.)=(4.16\pm0.24\pm0.46)\times10^{-5},$ and $\mathcal{B}(\chi_{c2}\to p \bar p K^{0}_{S} K^- \pi^+ + c.c.)=(5.63\pm0.28\pm0.46)\times10^{-5}$, respectively. The processes $\chi_{c1,2} \to \bar{p} \Lambda(1520) K^0_S \pi^{+} + c.c.$ are also observed, with statistical significances of 5.7$\sigma$ and 7.0$\sigma$, respectively. Evidence for $\chi_{c0} \to\bar{p} \Lambda(1520) K^0_S \pi^{+} + c.c.$ is found with statistical significances of 3.3$\sigma$ each. The corresponding branching fractions are determined to be $\mathcal{B}(\chi_{c0}\to \bar{p} \Lambda(1520) K^0_S \pi^{+} + c.c.) =(1.61^{+0.68}_{-0.64}\pm0.23)\times10^{-5}$, $\mathcal{B}(\chi_{c1}\to \bar{p} \Lambda(1520) K^0_S \pi^{+} + c.c.)=(4.06^{+0.80}_{-0.76}\pm0.52)\times10^{-5}$, and $\mathcal{B}(\chi_{c2}\to \bar{p} \Lambda(1520) K^0_S \pi^{+} + c.c.)=(4.09^{+0.87}_{-0.84}\pm0.42)\times10^{-5}$. Here, the first uncertainties are statistical and the second ones are systematic., Comment: 12 pages, 5 figures

Published
2024

37. Observation of $D^+\to\eta^\prime\mu^+\nu_\mu$ and First Study of $D^+\to \eta^\prime \ell^+\nu_\ell$ Decay Dynamics

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., An, Q., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chang, J. F., Che, G. R., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Chen, Z. Y., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, L., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, X. T., Huang, Y. P., Huang, Y. S., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Jeong, J. H., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lane, J. J., Lavezzi, L., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, L. J., Li, L. K., Li, Lei, Li, M. H., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, S. X., Li, T., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, J. Y., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, X. L., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, L. R., Ma, M. M., Ma, Q. M., Ma, R. Q., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y., Ma, Y. M., Maas, F. E., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pathak, A., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H., Qi, H. R., Qi, M., Qi, T. Y., Qian, S., Qian, W. B., Qiao, C. F., Qiao, X. K., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. P., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, H. C., Shi, J. L., Shi, J. Y., Shi, Q. Q., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, S. S, Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, W. Y., Sun, Y., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tao, Q. T., Tat, M., Teng, J. X., Thoren, V., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, B. L., Wang, Bo, Wang, D. Y., Wang, F., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wang, Ziyi, Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, X., Wu, X. H., Wu, Y., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, S. Y., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, H. Y., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W., Xu, W. L., Xu, X. P., Xu, Y., Xu, Y. C., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, J. H., Yin, Junhao, You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, M. C., Yu, T., Yu, X. D., Yu, Y. C., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. D., Zhang, X. M., Zhang, X. Y, Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. Y., Zhang, Z. Z., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, H., Zhou, J. Y., Zhou, L. P., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhou, Z. C., Zhu, A. N., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, T. J., Zhu, W. D., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment
Abstract

Using $20.3\,\rm fb^{-1}$ of $e^+e^-$ collision data collected at the center-of-mass energy 3.773\,GeV with the BESIII detector, we report the first observation of the semileptonic decay $D^+\to \eta^\prime \mu^+\nu_\mu$ with significance of $8.6\sigma$ including systematic uncertainties, and an improved measurement of $D^+\to \eta^\prime e^+\nu_e$. The branching fractions of $D^+\to \eta^\prime \mu^+\nu_\mu$ and $D^+\to \eta^\prime e^+\nu_e$ are determined to be $(1.92\pm0.28_{\rm stat}\pm 0.08_{\rm syst})\times 10^{-4}$ and $(1.79\pm0.19_{\rm stat}\pm 0.07_{\rm syst})\times 10^{-4}$, respectively. From an analysis of the $D^+\to \eta^\prime \ell^+\nu_\ell$ decay dynamics, the product of the hadronic form factor $f_+^{\eta^{\prime}}(0)$ and the CKM matrix element $|V_{cd}|$ is measured for the first time, giving $f^{\eta^\prime}_+(0)|V_{cd}| = (5.92\pm0.56_{\rm stat}\pm0.13_{\rm syst})\times 10^{-2}$. No evidence for violation of $\mu-e$ lepton-flavor universality is found in both the full range and several bins of $\ell^+\nu_\ell$ four-momentum transfer. The $\eta-\eta^\prime$ mixing angle in the quark flavor basis is determined to be $\phi_{\rm P} =(39.8\pm0.8_{\rm stat}\pm0.3_{\rm syst})^\circ$.

Published
2024

38. Precision Measurement of the Branching Fraction of $D^{+}\to \mu^{+}\nu_{\mu}$

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., An, Q., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chang, J. F., Che, G. R., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Chen, Z. Y., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, L., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, X. T., Huang, Y. P., Huang, Y. S., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Jeong, J. H., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lane, J. J., Lavezzi, L., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, K. L., Li, L. J., Li, L. K., Li, Lei, Li, M. H., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, S. X., Li, T., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, J. Y., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, X. L., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, L. R., Ma, M. M., Ma, Q. M., Ma, R. Q., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y., Ma, Y. M., Maas, F. E., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pathak, A., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H., Qi, H. R., Qi, M., Qi, T. Y., Qian, S., Qian, W. B., Qiao, C. F., Qiao, X. K., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. P., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, H. C., Shi, J. L., Shi, J. Y., Shi, Q. Q., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, S. S, Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, W. Y., Sun, Y., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tao, Q. T., Tat, M., Teng, J. X., Thoren, V., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, B. L., Wang, Bo, Wang, D. Y., Wang, F., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wang, Ziyi, Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, X., Wu, X. H., Wu, Y., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, S. Y., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, H. Y., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W., Xu, W. L., Xu, X. P., Xu, Y., Xu, Y. C., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, J. H., Yin, Junhao, You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, M. C., Yu, T., Yu, X. D., Yu, Y. C., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. D., Zhang, X. M., Zhang, X. Y, Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. Y., Zhang, Z. Z., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, H., Zhou, J. Y., Zhou, L. P., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhou, Z. C., Zhu, A. N., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, T. J., Zhu, W. D., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment
Abstract

Using $20.3~\mathrm{fb}^{-1}$ of $e^+e^-$ collision data collected at a center-of-mass energy of $E_{\rm cm}=3.773$ GeV with the BESIII detector operating at the BEPCII collider, we determine the branching fraction of the leptonic decay $D^+\to\mu^+\nu_\mu$ to be $(3.981\pm0.079_{\rm stat}\pm0.040_{\rm syst})\times10^{-4}$. Interpreting our measurement with knowledge of the Fermi coupling constant $G_F$, the masses of the $D^+$ and $\mu^+$ as well as the lifetime of the $D^+$, we determine $f_{D^+}|V_{cd}|=(47.53\pm0.48_{\rm stat}\pm0.24_{\rm syst}\pm0.12_{\rm input})~\mathrm{MeV}$. This result is a factor of 2.3 more precise than the previous best measurement. Using the value of the magnitude of the Cabibbo-Kobayashi-Maskawa matrix element $|V_{cd}|$ given by the global standard model fit, we obtain the $D^+$ decay constant $f_{D^+}=(211.5\pm2.3_{\rm stat}\pm1.1_{\rm syst}\pm0.8_{\rm input})$ MeV. Alternatively, using the value of $f_{D^+}$ from a precise lattice quantum chromodynamics calculation, we extract $|V_{cd}|=0.2242\pm0.0023_{\rm stat}\pm0.0011_{\rm syst}\pm0.0009_{\rm input}$., Comment: 9 pages, 2 figures

Published
2024

39. Search for the radiative decays $D^+\to\gamma\rho^+$ and $D^+\to\gamma K^{*+}$

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., An, Q., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chai, X. Y., Chang, J. F., Che, G. R., Che, Y. Z., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Chen, Z. Y., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, L., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, Q. P., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, X. T., Huang, Y. P., Huang, Y. S., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lane, J. J., Lavezzi, L., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, K. L., Li, L. J., Li, L. K., Li, Lei, Li, M. H., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, S. X., Li, T., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, J. Y., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, X. L., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, L. R., Ma, M. M., Ma, Q. M., Ma, R. Q., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y. M., Maas, F. E., MacKay, I., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H., Qi, H. R., Qi, M., Qi, T. Y., Qian, S., Qian, W. B., Qiao, C. F., Qiao, J. H., Qiao, X. K., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. P., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, M. Q., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, J. L., Shi, J. Y., Shi, Q. Q., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, S. S, Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, W. Y., Sun, Y., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tao, Q. T., Tat, M., Teng, J. X., Thoren, V., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, B. L., Wang, Bo, Wang, D. Y., Wang, F., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, L. W., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. H., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wang, Ziyi, Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, X., Wu, X. H., Wu, Y., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, S. Y., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, H. Y., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W., Xu, W. L., Xu, X. P., Xu, Y., Xu, Y. C., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, J. H., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, J. H., Yin, Junhao, You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, M. C., Yu, T., Yu, X. D., Yu, Y. C., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. M., Zhang, X. Y, Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. Y., Zhang, Z. Z., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, J. Y., Zhou, L. P., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhou, Z. C., Zhu, A. N., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, T. J., Zhu, W. D., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment
Abstract

We search for the radiative decays $D^{+} \to \gamma \rho^+$ and $D^{+} \to \gamma K^{*+}$ using 20.3~fb$^{-1}$ of $e^+e^-$ annihilation data collected at the center-of-mass energy $\sqrt{s}=3.773$ GeV by the BESIII detector operating at the BEPCII collider. No significant signals are observed, and the upper limits on the branching fractions of $D^{+} \to \gamma \rho^+$ and $D^{+} \to \gamma K^{*+}$ at 90\% confidence level are set to be $1.3\times10^{-5}$ and $1.8\times10^{-5}$, respectively.

Published
2024

40. Search for lepton number violating decays of $D_s^+\to h^-h^0e^+e^+$

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., An, Q., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chai, X. Y., Chang, J. F., Che, G. R., Che, Y. Z., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Chen, Z. Y., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, L., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, Q. P., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, X. T., Huang, Y. P., Huang, Y. S., Huang, Z. Y., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Jeong, J. H., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lavezzi, L., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, K. L., Li, L. J., Li, L. K., Li, Lei, Li, M. H., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, S. X., Li, T., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, J. Y., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, X. Y., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, X. L., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, L. R., Ma, M. M., Ma, Q. M., Ma, R. Q., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y. M., Maas, F. E., MacKay, I., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pathak, A., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H., Qi, H. R., Qi, M., Qi, T. Y., Qian, S., Qian, W. B., Qiao, C. F., Qiao, X. K., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. P., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, M. Q., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, H. C., Shi, J. L., Shi, J. Y., Shi, Q. Q., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, S. S, Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, W. Y., Sun, Y., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tao, Q. T., Tat, M., Teng, J. X., Thoren, V., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, B. L., Wang, Bo, Wang, D. Y., Wang, F., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. H., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wang, Ziyi, Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, X., Wu, X. H., Wu, Y., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, S. Y., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, H. Y., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W., Xu, W. L., Xu, X. P., Xu, Y., Xu, Y. C., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, J. H., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, J. H., Yin, Junhao, You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, M. C., Yu, T., Yu, X. D., Yu, Y. C., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. M., Zhang, X. Y, Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. Y., Zhang, Z. Z., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, H., Zhou, J. Y., Zhou, L. P., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhou, Z. C., Zhu, A. N., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, T. J., Zhu, W. D., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment
Abstract

Based on 7.33 fb$^{-1}$ of $e^+e^-$ collision data collected by the BESIII detector operating at the BEPCII collider at center-of-mass energies from 4.128 to 4.226 GeV, a search for the Majorana neutrino $\nu_m$ is conducted in the lepton-number-violating decays of $D_s^+\to h^-h^0e^+e^+$. Here, $h^-$ represents a $K^-$ or $\pi^-$, and $h^0$ represents a $\pi^0$, $K_S^0$ or $\phi$. No significant signal is observed, and the upper limits of their branching fractions at the 90\% confidence level are determined to be $\mathcal{B}(D_s^+\to \phi\pi^-e^+e^+) < 6.9 \times 10^{-5}$, $\mathcal{B}(D_s^+\to \phi K^-e^+e^+) < 9.9 \times 10^{-5}$, $\mathcal{B}(D_s^+\to K_S^0\pi^-e^+e^+) < 1.3 \times 10^{-5}$, $\mathcal{B}(D_s^+\to K_S^0K^-e^+e^+) < 2.9 \times 10^{-5}$, $\mathcal{B}(D_s^+\to \pi^-\pi^0e^+e^+) < 2.9 \times 10^{-5}$ and $\mathcal{B}(D_s^+\to K^-\pi^0e^+e^+) < 3.4 \times 10^{-5}$. The Majorana neutrino is searched for with different mass assumptions within the range [0.20, 0.80] GeV$/c^2$ in the decay of $D_s^+\to\phi e^+\nu_m$ with $\nu_m\to\pi^-e^+$, and the upper limits of the branching fractions at the 90\% confidence level are at the level of $10^{-5}-10^{-2}$, depending on the mass of the Majorana neutrino.

Published
2024

41. Gene Mutation Analysis in Papillary Thyroid Carcinoma Using a Multi-Gene Panel in China

Author

Wang Q, Zhao N, and Zhang J

Subjects
papillary thyroid carcinoma, thyroid cancer, braf, gene panel, Medicine (General), R5-920
Abstract

Qiang Wang,1,2 Ning Zhao,1 Jun Zhang1 1Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of Thyroid surgery, Shanxi Provincial People’s Hospital Affiliated to Shanxi Medical University, Taiyuan, 030000, People’s Republic of ChinaCorrespondence: Jun ZhangDepartment of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, People’s Republic of ChinaTel +86 13811055986Email zhangjun5986@ccmu.edu.cnPurpose: To detect low-frequency mutation in the 57 genes of small panels that are associated with developing thyroid cancer in papillary thyroid carcinoma (PTC) patients and provide patients with precise-targeted therapy.Patients and Methods: This study included 144 patients diagnosed with PTC who underwent total thyroidectomy and lymph node dissection in the central area of the neck between May 2017 and October 2018. We performed ultra-deep sequencing of 57 genes from 144 patients and detected the 57 genes mutations with bioinformatics.Results: There were 698 mutations in 45 genes from 138 PTC patients. A high frequency of mutations was detected in the RBM10 gene (44%) and TERT (43%), and some hotspot mutations, such as RBM10:p.E119D and TERT:p.P112fs, were also found.Conclusion: Ultra-deep sequencing of small gene panels can find some low-frequency mutation genes, which can provide targeted therapy for patients.Keywords: papillary thyroid carcinoma, thyroid cancer, BRAF, gene panel

Published
2021

42. PD-L1 Protein Expression and Gene Amplification Correlate with the Clinicopathological Characteristics and Prognosis of Lung Squamous Cell Carcinoma

Author

Chen Z, Zhao N, Wang Q, Xi Y, Tian X, Wu H, and Xu Y

Subjects
pd-l1 protein expression, pd-l1 gene amplification, lung squamous cell carcinoma, prognosis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Zhenwen Chen,1,2,&ast; Ning Zhao,1,&ast; Qi Wang,1 Yanfeng Xi,3 Xiaoai Tian,2 Huiwen Wu,1 Yirong Xu1,2 1Department of Pathology, Fenyang College of Shanxi Medical University, Fenyang, 032200, Shanxi Province, People’s Republic of China; 2Department of Pathology, Shanxi Fenyang Hospital, Fenyang, Shanxi Province, People’s Republic of China; 3Department of Pathology, Shanxi Cancer Hospital (Shanxi Institute of Oncology), Taiyuan, Shanxi Province, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Huiwen Wu; Yirong XuDepartment of Pathology, Fenyang College of Shanxi Medical University, No. 16 Xueyuan Road, Fenyang, 032200, Shanxi Province, People’s Republic of ChinaTel +86 151 3588 2981Email yirongxu@163.comPurpose: To investigate PD-L1 protein expression and gene amplification in lung squamous cell carcinoma (LUSC) and analyse their correlation with the clinicopathological characteristics and prognosis of LUSC patients.Patients and Methods: Tissue samples from 164 LUSC patients were collected. PD-L1 protein was detected by immunochemistry (IHC), and PD-L1 gene amplification was investigated by fluorescence in situ hybridization in LUSC patients.Results: The positive expression rate of PD-L1 in LUSC was 47.6% (78/164), and the amplification rate of PD-L1 was 6.7% (11/164); both rates were higher than those of paratumor tissue. Both PD-L1 positive expression and gene amplification were correlated with clinical stage and lymph node metastasis (P< 0.05). PD-L1 protein expression, PD-L1 gene amplification, late stage, lymph node metastasis and distant metastasis were significantly correlated with the prognosis of patients. Among these factors, late stage, lymph node metastasis, PD-L1 protein expression and PD-L1 gene amplification were independent prognostic factors for LUSC.Conclusion: Positive PD-L1 protein expression and gene amplification are involved in the malignant progression and metastasis of LUSC. Both PD-L1 protein expression and gene amplification are associated with poor prognosis.Keywords: PD-L1 protein expression, PD-L1 gene amplification, lung squamous cell carcinoma, prognosis

Published
2021

43. Efficacy of Venetoclax Combined with Decitabine-Based Treatment for Heavily Pre-Treated Relapsed or Refractory AML Patients in a Real-World Setting

Author

Tong J, Zhao N, Hu X, Yao W, Cheng Y, Zhou L, Liu H, Geng L, Sun Z, and Zheng C

Subjects
venetoclax, hypomethylating agents, acute myeloid leukaemia, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Juan Tong, Na Zhao, Xing Hu, Wen Yao, Yaxin Cheng, Li Zhou, Huilan Liu, Liangquan Geng, Zimin Sun, Changcheng Zheng Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People’s Republic of ChinaCorrespondence: Changcheng ZhengDepartment of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Lujiang Road No. 17, Hefei, 230001, People’s Republic of ChinaTel +86-551-62284476Fax +86-551-62284476Email zhengchch1123@ustc.edu.cnPurpose: We report the efficacy and safety of venetoclax plus decitabine-based treatment in heavily pre-treated relapsed or refractory acute myeloid leukaemia (RR-AML) in a real-world setting.Patients and Methods: There were 22 patients in this study and the median age was 47.5 (12– 84) years old, including 11 males and 11 females. Among them, 8 patients were relapsed AML including 2 patients relapsed after HSCT and 14 patients with primary refractory AML including 4 secondary AML. The median number of cycles of previous chemotherapy was 4 (range, 2– 10).Results: After a course of venetoclax plus decitabine-based treatment, 9 patients achieved complete remission (CR) and 1 patient achieved complete remission with incomplete haematological recovery (CRi). The overall response rate (ORR) was 45.5% and the CR rate was 40.9%, and the median time to reach CR/CRi was 21 (13– 46) days. Four of the 10 CR/CRi patients relapsed again, and the median time of relapse was 5 (1.0– 24) months. The one-year overall survival rate was 31.8%, and the median survival time was 6 months (95% CI, 1– 9 months). The one-year overall survival rate of 10 CR/CRi patients was 59.1%, and the 12 NR patients was 10.4% (p=0.001). Nausea and vomiting occurred in 11 patients (50.0%). All patients had grade IV neutropenia and IV thrombocytopenia (100%). Pneumonia occurred in 14 patients (63.6%) and septicaemia occurred in 2 patients (9.0%). The cause of death in all patients was primary disease progression, and no patients died due to the side effects.Conclusion: The efficacy of venetoclax plus decitabine-based treatment in the real-world treatment of heavily pre-treated RR-AML is similar to that in clinical trials, and the side effects are controllable.Keywords: venetoclax, hypomethylating agents, acute myeloid leukaemia

Published
2021

44. The Red Blood Cell Distribution Width–Albumin Ratio: A Promising Predictor of Mortality in Stroke Patients

Author

Zhao N, Hu W, Wu Z, Wu X, Li W, Wang Y, and Zhao H

Subjects
red blood cell distribution width - albumin ratio, stroke-associated infection, stroke, all-cause mortality, Medicine (General), R5-920
Abstract

Na Zhao,1 WanHua Hu,1 Zhimin Wu,1 Xujie Wu,1 Wei Li,1 Yiru Wang,1 Han Zhao2 1Department of Neurology, Wenzhou Hospital of Traditional Chinese Medicine, Zhejiang, Wenzhou, 325000, People’s Republic of China; 2Department of Neurology, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Zhejiang, Wenzhou, 325000, People’s Republic of ChinaCorrespondence: Han Zhao Email zhaohan0577@sina.comObjective: Within this study we attempt to express a correlation between the mortality of stroke and stroke related infection to a novel biomarker represented by the red blood cell width–albumin levels ratio within the patient. We hypothesize that this novel biomarker could be utilized as better predictive tool for stroke associated infections.Methods: Patient data sets were obtained via the Medical Information Mart for Intensive Care Database iii V1.4 (MIMIC-iii). Data from 1480 patients were obtained to serve the testing for the RA biomarker tests. Clinical endpoints of 30-, 60-, and 365-day all-cause mortality in stroke patients were used as subgroups within the analyzed population. Estimation of hazard ratios (HR) were obtained from Cox regression models for stroke-associated infection and all-cause mortality in relation to RA values.Results: A high-RA was associated with increased mortality in ICU patients suffering from a stroke. After adjusting for age and sex, compared to the reference group (the first quartile), the high-RA group had the highest 30-day (HR, 95% CI: 1.88 (1.36, 2.58)), 90-day (HR, 95% CI: 2.12 (1.59, 2.82)), and one-year (HR, 95% CI: 2.15 (1.65, 2.80)) all-cause mortality. The RA values were independently associated with an increased risk of stroke-associated infection when adjusting for confounders.Conclusions: Our data suggest RA may be an easily accessible, reproducible, and low-cost biomarker for predicting stroke-associated infections and mortality in patients who have suffered from a stroke.Keywords: red blood cell distribution width–albumin ratio, stroke-associated infection, stroke, all-cause mortality

Published
2021

45. Imbalance of T Lymphocyte Subsets in Adult Immune Thrombocytopenia

Author

Lin X, Xu A, Zhou L, Zhao N, Zhang X, Xu J, Feng S, and Zheng C

Subjects
primary immune thrombocytopenia, t helper cells, cytotoxic t lymphocyte, regulatory t cells, Medicine (General), R5-920
Abstract

Xiuxiu Lin,1 Anhui Xu,1 Li Zhou,1 Na Zhao,1 Xinhui Zhang,2 Jin Xu,3 Shanglong Feng,2 Changcheng Zheng1 1Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People’s Republic of China; 2Department of Hematology, Anhui Provincial Hospital, Anhui Medical University, Hefei, People’s Republic of China; 3Wannan Medical College, Wuhu, People’s Republic of ChinaCorrespondence: Changcheng ZhengDepartment of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People’s Republic of ChinaTel/ Fax +86-551-62284476Email zhengchch1123@ustc.edu.cnBackground: Primary immune thrombocytopenia (ITP) is defined as an acquired autoimmune disease characterized by isolated thrombocytopenia. This work is to further clarify the relationship between T cell immune dysfunction and the pathogenesis of ITP.Methods: 37 adult patients with ITP were selected and were classified into newly diagnosed ITP (nITP, n = 13), persistent ITP (pITP, n = 6) and chronic ITP (cITP n = 18). The frequency of cytotoxic T lymphocytes (Tc1, Tc2, and Tc17) and helper T cells (Th1, Th2, and Th17), Tregs, and the expression of chemokine receptors and PD-1 on CD4+ T cells were investigated by flow cytometry. Plasma levels of T cell-related cytokines (IL-2, IL-4, IL-6, IL-10, TNF-α, IFN-γ, IL-17) were measured by cytometric beads array (CBA).Results: The percentage of Tc1 in cITP was greatly higher than nITP and healthy controls (p < 0.05, p < 0.01). The percentage of Treg in nITP and cITP groups was remarkably lower than those in healthy control group (p < 0.05, p < 0.001); and according to platelet count analysis (PLT< 50x109/L or PLT> 50x109/L), Treg cells in ITP group were significantly lower than those in healthy control group (p < 0.001, p < 0.05). The percentage of CD4+CXCR3+ of cITP was significantly higher than healthy controls and nITP (p < 0.01, p < 0.05). The percentage of CD4+CCR6+ in cITP was significantly higher than healthy controls and nITP (p < 0.001, p < 0.05). The expression of PD-1 in cITP patients was higher than healthy control (p < 0.05), but there was no significant difference among nITP, pITP and cITP (p = 0.25). The levels of IL-2, IFN-γ and TNFα in nITP group and cITP group were significantly higher than those in healthy control group (p < 0.01, p < 0.05; p < 0.01, p < 0.05; p < 0.05, p < 0.05), and the level of IL-10 in nITP group was significantly higher than that in pITP group (p < 0.05).Conclusion: Our results suggest that T lymphocyte immune dysfunction does exist in adult ITP patients and plays an important role in the pathogenesis of ITP.Keywords: primary immune thrombocytopenia, T helper cells, cytotoxic T lymphocyte, regulatory T cells

Published
2021

46. Clinical Utility of Central and Peripheral Airway Nitric Oxide in Aging Patients with Stable and Acute Exacerbated Chronic Obstructive Pulmonary Disease

Author

Fan X, Zhao N, Yu Z, Yu H, Yin B, Zou L, Zhao Y, Qian X, Sai X, Qin C, Fu C, Hu C, Di T, Yang Y, Wu Y, and Bian T

Subjects
exhaled nitric oxide, chronic obstruction pulmonary disease, corticosteroid, biomarker, Medicine (General), R5-920
Abstract

Xiaodong Fan,1,* Nian Zhao,2,3,* Zhen Yu,1 Haoda Yu,1 Bo Yin,1 Lifei Zou,1 Yinying Zhao,1 Xiufen Qian,1 Xiaoyan Sai,1 Chu Qin,1 Congli Fu,1 Caixia Hu,1 Tingting Di,1 Yue Yang,1 Yan Wu,1 Tao Bian1 1Departments of Pulmonary and Critical Care Medicine, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu, 214023, People’s Republic of China; 2Departments of Pulmonary and Critical Care Medicine, The First People’s Hospital of Kunshan, Kunshan, Jiangsu, 215300, People’s Republic of China; 3The first medical college of Nanjing Medical University, NanJing, Jiangsu, 211166, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yan Wu; Tao BianDepartment of Pulmonary and Critical Care Medicine, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu, 214023, People’s Republic of ChinaEmail wuyanyangting@163.com; biantaophd@126.comPurpose: Exhaled nitric oxide has been used as a marker of airway inflammation. The NO concentration in the central and peripheral airway/alveolar can be measured by a slow and fast exhalation flow rate to evaluate inflammation in different divisions within the respiratory tract. We hypothesized that FeNO200 (exhaled NO at a flow rate of 200mL/s) could be used as an evaluation tool for peripheral airway/alveolar inflammation and corticosteroid therapy in chronic obstructive pulmonary disease (COPD) patients.Methods: We recruited 171 subjects into the study: 73 healthy controls, 59 stable COPD patients, and 39 acute exacerbations of COPD (AECOPD) patients. Exhaled nitric oxide (FeNO50 (exhaled NO at a flow rate of 50mL/s)), FeNO200 and CaNO (peripheral concentration of NO/alveolar NO) and clinical variables including pulmonary function, COPD Assessment Test (CAT), C-reactive protein concentration (CRP) and circulating eosinophil count were measured among the recruited participants. FeNO50, FeNO200 and CaNO were repeatedly evaluated in 39 AECOPD patients after corticosteroid treatment.Results: FeNO200 was significantly higher in stable COPD and AECOPD patients than in healthy controls. Nevertheless, CaNO could not differentiate COPD from healthy controls. No correlation was found between circulating eosinophil counts or FEV1 and exhaled nitric oxide (FeNO50, FeNO200, CaNO) in COPD patients. For AECOPD patients, 64% of patients had eosinophil counts > 100 cells/μL; 59% of patients had FeNO200 > 10 ppb; only 31% of patients had FeNO50 > 25 ppb. Among AECOPD patients, the high FeNO50 and FeNO200 groups’ levels were significantly lower than their baseline levels, and significant improvements in CAT were seen in the two groups after corticosteroid treatment. These implied a good corticosteroid response in AECOPD patients with FeNO200> 10ppb.Conclusion: FeNO200 is a straightforward and feasible method to evaluate the peripheral NO concentration in COPD. FeNO200 can be a type 2 inflammation biomarker and a useful tool for predicting corticosteroid therapy in COPD.Keywords: exhaled nitric oxide, chronic obstruction pulmonary disease, corticosteroid, biomarker

Published
2021

47. Search for $D^0\to K^-\eta e^+\nu_e$, $D^+\to K_S^0 \eta e^+\nu_e$ and $D^+\to \eta\eta e^+\nu_e$ decays

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., An, Q., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chang, J. F., Che, G. R., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Chen, Z. Y., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, L., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, X. T., Huang, Y. P., Huang, Y. S., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Jeong, J. H., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lane, J. J., Lavezzi, L., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, L. J., Li, L. K., Li, Lei, Li, M. H., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, S. X., Li, T., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, J. Y., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, X. L., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, M. M., Ma, Q. M., Ma, R. Q., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y., Ma, Y. M., Maas, F. E., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pathak, A., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H., Qi, H. R., Qi, M., Qi, T. Y., Qian, S., Qian, W. B., Qiao, C. F., Qiao, X. K., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. P., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, H. C., Shi, J. L., Shi, J. Y., Shi, Q. Q., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, W. Y., Sun, Y., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tao, Q. T., Tat, M., Teng, J. X., Thoren, V., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, B. L., Wang, Bo, Wang, D. Y., Wang, F., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wang, Ziyi, Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, X., Wu, X. H., Wu, Y., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, S. Y., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, H. Y., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W., Xu, W. L., Xu, X. P., Xu, Y. C., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, J. H., You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, T., Yu, X. D., Yu, Y. C., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. D., Zhang, X. M., Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. Y., Zhang, Z. Z., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, H., Zhou, J. Y., Zhou, L. P., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, T. J., Zhu, W. D., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment
Abstract

By analyzing $e^+e^-$ annihilation data corresponding to an integrated luminosity of 7.93 fb$^{-1}$, collected at the center-of-mass energy of 3.773 GeV with the BESIII detector, we search for the semileptonic decays $D^0\to K^-\eta e^+\nu_e$, $D^+\to K_S^0 \eta e^+\nu_e$ and $D^+\to \eta\eta e^+\nu_e$ for the first time. We present evidence for $D^0\to K^-\eta e^+\nu_e$ with a significance of $3.3\sigma$. The branching fraction of $D^0\to K^-\eta e^+\nu_e$ is measured to be $(0.84_{-0.34}^{+0.29}\pm0.22)\times 10^{-4}$. Here, the first uncertainties are statistical and the second ones are systematic. No significant signals are observed for the decays $D^+\to K_S^0 \eta e^+\nu_e$ and $D^+\to \eta\eta e^+\nu_e$ and we set the upper limits on their branching fractions., Comment: 10 pages,4 figures

Published
2024

48. Measurements of the $CP$-even fractions of $D^0\to\pi^{+}\pi^{-}\pi^{0}$ and $D^0\to K^{+}K^{-}\pi^{0}$ at BESIII

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., An, Q., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chai, X. Y., Chang, J. F., Che, G. R., Che, Y. Z., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Chen, Z. Y., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, L., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, Q. P., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, X. T., Huang, Y. P., Huang, Y. S., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Jeong, J. H., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lane, J. J., Lavezzi, L., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, K. L., Li, L. J., Li, L. K., Li, Lei, Li, M. H., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, S. X., Li, T., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, J. Y., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, X. L., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, L. R., Ma, M. M., Ma, Q. M., Ma, R. Q., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y. M., Maas, F. E., MacKay, I., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pathak, A., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H., Qi, H. R., Qi, M., Qi, T. Y., Qian, S., Qian, W. B., Qiao, C. F., Qiao, X. K., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. P., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, M. Q., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, H. C., Shi, J. L., Shi, J. Y., Shi, Q. Q., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, S. S, Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, W. Y., Sun, Y., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tao, Q. T., Tat, M., Teng, J. X., Thoren, V., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, B. L., Wang, Bo, Wang, D. Y., Wang, F., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wang, Ziyi, Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, X., Wu, X. H., Wu, Y., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, S. Y., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, H. Y., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W., Xu, W. L., Xu, X. P., Xu, Y., Xu, Y. C., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, J. H., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, J. H., Yin, Junhao, You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, M. C., Yu, T., Yu, X. D., Yu, Y. C., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. M., Zhang, X. Y, Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. Y., Zhang, Z. Z., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, H., Zhou, J. Y., Zhou, L. P., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhou, Z. C., Zhu, A. N., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, T. J., Zhu, W. D., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment
Abstract

The $CP$-even fractions ($F_{+}$) of the decays $D^0\to\pi^{+}\pi^{-}\pi^{0}$ and $D^0\to K^{+}K^{-}\pi^{0}$ are measured with a quantum-correlated $\psi(3770)\to D\bar{D}$ data sample collected by the BESIII experiment corresponding to an integrated luminosity of 7.93 $\mathrm{fb}^{-1}$. The results are $F_{+}^{\pi^{+}\pi^{-}\pi^{0}}=0.9406\pm0.0036\pm0.0021$ and $F_{+}^{K^{+}K^{-}\pi^{0}}=0.631\pm0.014\pm0.011$, where the first uncertainties are statistical and the second systematic. These measurements are consistent with the previous determinations, and the uncertainties for $F_{+}^{\pi^{+}\pi^{-}\pi^{0}}$ and $F_{+}^{K^{+}K^{-}\pi^{0}}$ are reduced by factors of 3.9 and 2.6, respectively. The reported results provide important inputs for the precise measurement of the angle $\gamma$ of the Cabibbo-Kobayashi-Maskawa matrix and indirect $CP$ violation in charm mixing., Comment: 19 pages, 8 figures

Published
2024

49. Study of the decay $D^0\rightarrow \rho(770)^-e^+\nu_e$

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., An, Q., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chai, X. Y., Chang, J. F., Che, G. R., Che, Y. Z., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Chen, Z. Y., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, L., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, X. T., Huang, Y. P., Huang, Y. S., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Jeong, J. H., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lane, J. J., Lavezzi, L., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, K. L., Li, L. J., Li, L. K., Li, Lei, Li, M. H., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, S. X., Li, T., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, J. Y., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, X. L., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, L. R., Ma, M. M., Ma, Q. M., Ma, R. Q., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y. M., Maas, F. E., MacKay, I., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pathak, A., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H., Qi, H. R., Qi, M., Qi, T. Y., Qian, S., Qian, W. B., Qiao, C. F., Qiao, X. K., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. P., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, M. Q., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, H. C., Shi, J. L., Shi, J. Y., Shi, Q. Q., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, S. S, Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, W. Y., Sun, Y., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tao, Q. T., Tat, M., Teng, J. X., Thoren, V., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, B. L., Wang, Bo, Wang, D. Y., Wang, F., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wang, Ziyi, Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, X., Wu, X. H., Wu, Y., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, S. Y., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, H. Y., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W., Xu, W. L., Xu, X. P., Xu, Y., Xu, Y. C., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, J. H., Yin, Junhao, You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, M. C., Yu, T., Yu, X. D., Yu, Y. C., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. M., Zhang, X. Y, Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. Y., Zhang, Z. Z., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, H., Zhou, J. Y., Zhou, L. P., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhou, Z. C., Zhu, A. N., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, T. J., Zhu, W. D., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment
Abstract

We present a study of the semileptonic decay $D^0\rightarrow \pi^-\pi^0e^{+}\nu_{e}$ using an $e^+e^-$ annihilation data sample of $7.93~\mathrm{fb}^{-1}$ collected at the center-of-mass energy of 3.773 GeV with the BESIII detector. The branching fraction of $D^0\to \rho(770)^-e^+\nu_e$ is measured to be $(1.439 \pm 0.033(\rm stat.) \pm 0.027(\rm syst.)) \times10^{-3}$, which is a factor 1.6 more precise than previous measurements. By performing an amplitude analysis, we measure the hadronic form-factor ratios of $D^0\to \rho(770)^-e^+\nu_e$ at $q^2=0$ assuming the single-pole-dominance parametrization: $r_{V}=V(0)/A_1(0)=1.548\pm0.079(\rm stat.)\pm0.041(\rm syst.)$ and $r_{2}=A_2(0)/A_1(0)=0.823\pm0.056(\rm stat.)\pm0.026(\rm syst.)$., Comment: 12 pages, 3 figures

Published
2024

50. Search for the massless dark photon with $D^0\to\omega\gamma'$ and $D^0\to\gamma\gamma'$

Author

BESIII Collaboration, Ablikim, M., Achasov, M. N., Adlarson, P., Afedulidis, O., Ai, X. C., Aliberti, R., Amoroso, A., Bai, Y., Bakina, O., Balossino, I., Ban, Y., Bao, H. -R., Batozskaya, V., Begzsuren, K., Berger, N., Berlowski, M., Bertani, M., Bettoni, D., Bianchi, F., Bianco, E., Bortone, A., Boyko, I., Briere, R. A., Brueggemann, A., Cai, H., Cai, X., Calcaterra, A., Cao, G. F., Cao, N., Cetin, S. A., Chai, X. Y., Chang, J. F., Che, G. R., Che, Y. Z., Chelkov, G., Chen, C., Chen, C. H., Chen, Chao, Chen, G., Chen, H. S., Chen, H. Y., Chen, M. L., Chen, S. J., Chen, S. L., Chen, S. M., Chen, T., Chen, X. R., Chen, X. T., Chen, Y. B., Chen, Y. Q., Chen, Z. J., Chen, Z. Y., Choi, S. K., Cibinetto, G., Cossio, F., Cui, J. J., Dai, H. L., Dai, J. P., Dbeyssi, A., de Boer, R. E., Dedovich, D., Deng, C. Q., Deng, Z. Y., Denig, A., Denysenko, I., Destefanis, M., De Mori, F., Ding, B., Ding, X. X., Ding, Y., Dong, J., Dong, L. Y., Dong, M. Y., Dong, X., Du, M. C., Du, S. X., Duan, Y. Y., Duan, Z. H., Egorov, P., Fan, Y. H., Fang, J., Fang, S. S., Fang, W. X., Fang, Y., Fang, Y. Q., Farinelli, R., Fava, L., Feldbauer, F., Felici, G., Feng, C. Q., Feng, J. H., Feng, Y. T., Fritsch, M., Fu, C. D., Fu, J. L., Fu, Y. W., Gao, H., Gao, X. B., Gao, Y. N., Gao, Yang, Garbolino, S., Garzia, I., Ge, L., Ge, P. T., Ge, Z. W., Geng, C., Gersabeck, E. M., Gilman, A., Goetzen, K., Gong, L., Gong, W. X., Gradl, W., Gramigna, S., Greco, M., Gu, M. H., Gu, Y. T., Guan, C. Y., Guo, A. Q., Guo, L. B., Guo, M. J., Guo, R. P., Guo, Y. P., Guskov, A., Gutierrez, J., Han, K. L., Han, T. T., Hanisch, F., Hao, X. Q., Harris, F. A., He, K. K., He, K. L., Heinsius, F. H., Heinz, C. H., Heng, Y. K., Herold, C., Holtmann, T., Hong, P. C., Hou, G. Y., Hou, X. T., Hou, Y. R., Hou, Z. L., Hu, B. Y., Hu, H. M., Hu, J. F., Hu, Q. P., Hu, S. L., Hu, T., Hu, Y., Huang, G. S., Huang, K. X., Huang, L. Q., Huang, X. T., Huang, Y. P., Huang, Y. S., Hussain, T., Hölzken, F., Hüsken, N., der Wiesche, N. in, Jackson, J., Janchiv, S., Jeong, J. H., Ji, Q., Ji, Q. P., Ji, W., Ji, X. B., Ji, X. L., Ji, Y. Y., Jia, X. Q., Jia, Z. K., Jiang, D., Jiang, H. B., Jiang, P. C., Jiang, S. S., Jiang, T. J., Jiang, X. S., Jiang, Y., Jiao, J. B., Jiao, J. K., Jiao, Z., Jin, S., Jin, Y., Jing, M. Q., Jing, X. M., Johansson, T., Kabana, S., Kalantar-Nayestanaki, N., Kang, X. L., Kang, X. S., Kavatsyuk, M., Ke, B. C., Khachatryan, V., Khoukaz, A., Kiuchi, R., Kolcu, O. B., Kopf, B., Kuessner, M., Kui, X., Kumar, N., Kupsc, A., Kühn, W., Lavezzi, L., Lei, T. T., Lei, Z. H., Lellmann, M., Lenz, T., Li, C., Li, C. H., Li, Cheng, Li, D. M., Li, F., Li, G., Li, H. B., Li, H. J., Li, H. N., Li, Hui, Li, J. R., Li, J. S., Li, K., Li, K. L., Li, L. J., Li, L. K., Li, Lei, Li, M. H., Li, P. R., Li, Q. M., Li, Q. X., Li, R., Li, S. X., Li, T., Li, W. D., Li, W. G., Li, X., Li, X. H., Li, X. L., Li, X. Y., Li, X. Z., Li, Y. G., Li, Z. J., Li, Z. Y., Liang, C., Liang, H., Liang, Y. F., Liang, Y. T., Liao, G. R., Liao, Y. P., Libby, J., Limphirat, A., Lin, C. C., Lin, C. X., Lin, D. X., Lin, T., Liu, B. J., Liu, B. X., Liu, C., Liu, C. X., Liu, F., Liu, F. H., Liu, Feng, Liu, G. M., Liu, H., Liu, H. B., Liu, H. H., Liu, H. M., Liu, Huihui, Liu, J. B., Liu, J. Y., Liu, K., Liu, K. Y., Liu, Ke, Liu, L., Liu, L. C., Liu, Lu, Liu, M. H., Liu, P. L., Liu, Q., Liu, S. B., Liu, T., Liu, W. K., Liu, W. M., Liu, X., Liu, Y., Liu, Y. B., Liu, Z. A., Liu, Z. D., Liu, Z. Q., Lou, X. C., Lu, F. X., Lu, H. J., Lu, J. G., Lu, X. L., Lu, Y., Lu, Y. P., Lu, Z. H., Luo, C. L., Luo, J. R., Luo, M. X., Luo, T., Luo, X. L., Lyu, X. R., Lyu, Y. F., Ma, F. C., Ma, H., Ma, H. L., Ma, J. L., Ma, L. L., Ma, L. R., Ma, M. M., Ma, Q. M., Ma, R. Q., Ma, T., Ma, X. T., Ma, X. Y., Ma, Y. M., Maas, F. E., MacKay, I., Maggiora, M., Malde, S., Mao, Y. J., Mao, Z. P., Marcello, S., Meng, Z. X., Messchendorp, J. G., Mezzadri, G., Miao, H., Min, T. J., Mitchell, R. E., Mo, X. H., Moses, B., Muchnoi, N. Yu., Muskalla, J., Nefedov, Y., Nerling, F., Nie, L. S., Nikolaev, I. B., Ning, Z., Nisar, S., Niu, Q. L., Niu, W. D., Niu, Y., Olsen, S. L., Ouyang, Q., Pacetti, S., Pan, X., Pan, Y., Pathak, A., Pei, Y. P., Pelizaeus, M., Peng, H. P., Peng, Y. Y., Peters, K., Ping, J. L., Ping, R. G., Plura, S., Prasad, V., Qi, F. Z., Qi, H., Qi, H. R., Qi, M., Qi, T. Y., Qian, S., Qian, W. B., Qiao, C. F., Qiao, X. K., Qin, J. J., Qin, L. Q., Qin, L. Y., Qin, X. P., Qin, X. S., Qin, Z. H., Qiu, J. F., Qu, Z. H., Redmer, C. F., Ren, K. J., Rivetti, A., Rolo, M., Rong, G., Rosner, Ch., Ruan, M. Q., Ruan, S. N., Salone, N., Sarantsev, A., Schelhaas, Y., Schoenning, K., Scodeggio, M., Shan, K. Y., Shan, W., Shan, X. Y., Shang, Z. J., Shangguan, J. F., Shao, L. G., Shao, M., Shen, C. P., Shen, H. F., Shen, W. H., Shen, X. Y., Shi, B. A., Shi, H., Shi, H. C., Shi, J. L., Shi, J. Y., Shi, Q. Q., Shi, S. Y., Shi, X., Song, J. J., Song, T. Z., Song, W. M., Song, Y. J., Song, Y. X., Sosio, S., Spataro, S., Stieler, F., Su, S. S, Su, Y. J., Sun, G. B., Sun, G. X., Sun, H., Sun, H. K., Sun, J. F., Sun, K., Sun, L., Sun, S. S., Sun, T., Sun, W. Y., Sun, Y., Sun, Y. J., Sun, Y. Z., Sun, Z. Q., Sun, Z. T., Tang, C. J., Tang, G. Y., Tang, J., Tang, M., Tang, Y. A., Tao, L. Y., Tao, Q. T., Tat, M., Teng, J. X., Thoren, V., Tian, W. H., Tian, Y., Tian, Z. F., Uman, I., Wan, Y., Wang, S. J., Wang, B., Wang, B. L., Wang, Bo, Wang, D. Y., Wang, F., Wang, H. J., Wang, J. J., Wang, J. P., Wang, K., Wang, L. L., Wang, M., Wang, N. Y., Wang, S., Wang, T., Wang, T. J., Wang, W., Wang, W. P., Wang, X., Wang, X. F., Wang, X. J., Wang, X. L., Wang, X. N., Wang, Y., Wang, Y. D., Wang, Y. F., Wang, Y. H., Wang, Y. L., Wang, Y. N., Wang, Y. Q., Wang, Yaqian, Wang, Yi, Wang, Z., Wang, Z. L., Wang, Z. Y., Wang, Ziyi, Wei, D. H., Weidner, F., Wen, S. P., Wen, Y. R., Wiedner, U., Wilkinson, G., Wolke, M., Wollenberg, L., Wu, C., Wu, J. F., Wu, L. H., Wu, L. J., Wu, X., Wu, X. H., Wu, Y., Wu, Y. H., Wu, Y. J., Wu, Z., Xia, L., Xian, X. M., Xiang, B. H., Xiang, T., Xiao, D., Xiao, G. Y., Xiao, S. Y., Xiao, Y. L., Xiao, Z. J., Xie, C., Xie, X. H., Xie, Y., Xie, Y. G., Xie, Y. H., Xie, Z. P., Xing, T. Y., Xu, C. F., Xu, C. J., Xu, G. F., Xu, H. Y., Xu, M., Xu, Q. J., Xu, Q. N., Xu, W., Xu, W. L., Xu, X. P., Xu, Y., Xu, Y. C., Xu, Z. S., Yan, F., Yan, L., Yan, W. B., Yan, W. C., Yan, X. Q., Yang, H. J., Yang, H. L., Yang, H. X., Yang, J. H., Yang, T., Yang, Y., Yang, Y. F., Yang, Y. X., Yang, Z. W., Yao, Z. P., Ye, M., Ye, M. H., Yin, J. H., Yin, Junhao, You, Z. Y., Yu, B. X., Yu, C. X., Yu, G., Yu, J. S., Yu, M. C., Yu, T., Yu, X. D., Yu, Y. C., Yuan, C. Z., Yuan, J., Yuan, L., Yuan, S. C., Yuan, Y., Yuan, Z. Y., Yue, C. X., Zafar, A. A., Zeng, F. R., Zeng, S. H., Zeng, X., Zeng, Y., Zeng, Y. J., Zhai, X. Y., Zhai, Y. C., Zhan, Y. H., Zhang, A. Q., Zhang, B. L., Zhang, B. X., Zhang, D. H., Zhang, G. Y., Zhang, H., Zhang, H. C., Zhang, H. H., Zhang, H. Q., Zhang, H. R., Zhang, H. Y., Zhang, J., Zhang, J. J., Zhang, J. L., Zhang, J. Q., Zhang, J. S., Zhang, J. W., Zhang, J. X., Zhang, J. Y., Zhang, J. Z., Zhang, Jianyu, Zhang, L. M., Zhang, Lei, Zhang, P., Zhang, Q. Y., Zhang, R. Y., Zhang, S. H., Zhang, Shulei, Zhang, X. M., Zhang, X. Y, Zhang, X. Y., Zhang, Y., Zhang, Y. T., Zhang, Y. H., Zhang, Y. M., Zhang, Yan, Zhang, Z. D., Zhang, Z. H., Zhang, Z. L., Zhang, Z. Y., Zhang, Z. Z., Zhao, G., Zhao, J. Y., Zhao, J. Z., Zhao, L., Zhao, Lei, Zhao, M. G., Zhao, N., Zhao, R. P., Zhao, S. J., Zhao, Y. B., Zhao, Y. X., Zhao, Z. G., Zhemchugov, A., Zheng, B., Zheng, B. M., Zheng, J. P., Zheng, W. J., Zheng, Y. H., Zhong, B., Zhong, X., Zhou, H., Zhou, J. Y., Zhou, L. P., Zhou, S., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, X. Y., Zhou, Y. Z., Zhou, Z. C., Zhu, A. N., Zhu, J., Zhu, K., Zhu, K. J., Zhu, K. S., Zhu, L., Zhu, L. X., Zhu, S. H., Zhu, T. J., Zhu, W. D., Zhu, Y. C., Zhu, Z. A., Zou, J. H., and Zu, J.

Subjects
High Energy Physics - Experiment
Abstract

Using $7.9~\rm{fb^{-1}}$ of $e^+e^-$ collision data collected at $\sqrt{s}=3.773$ GeV with the BESIII detector at the BEPCII collider, we search for the massless dark photon with the flavor-changing neutral current processes $D^0\to\omega\gamma'$ and $D^0\to\gamma\gamma'$ for the first time. No significant signals are observed, and the upper limits at the 90% confidence level on the massless dark photon branching fraction are set to be $1.1\times10^{-5}$ and $2.0\times10^{-6}$ for $D^0\to\omega\gamma'$ and $D^0\to\gamma\gamma'$, respectively. These results provide the most stringent constraint on the new physics energy scale associated with $cu\gamma'$ coupling in the world, with the new physics energy scale related parameter $|\mathbb{C}|^2+|\mathbb{C}_5|^2<8.2\times10^{-17}~\rm{GeV}^{-2}$ at the 90% confidence level., Comment: 10 pages, 3 figures

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results